réservé à la recherche
N° Cat.S1208
| Cibles apparentées | HDAC PARP ATM/ATR DNA-PK WRN DNA/RNA Synthesis Topoisomerase PPAR Sirtuin Casein Kinase |
|---|---|
| Autre Antineoplastic and Immunosuppressive Antibiotics Inhibiteurs | Staurosporine (STS) Cyclosporin A Oligomycin A (MCH 32) Puromycin Dihydrochloride Nigericin sodium salt Geldanamycin (NSC 122750) Honokiol Streptozotocin (STZ) Sodium Monensin (NSC 343257) Cephalomannine |
| Lignées cellulaires | Type dessai | Concentration | Temps dincubation | Formulation | Description de lactivité | PMID |
|---|---|---|---|---|---|---|
| SGC7901 | Growth Inhibition Assay | 10 μM | 72 h | DMSO | GI50=0.55 μM | 24686011 |
| HLF | Growth Inhibition Assay | 10 μM | 72 h | DMSO | GI50=0.33 μM | 24686011 |
| 16HBE | Growth Inhibition Assay | 10 μM | 72 h | DMSO | GI50=0.18 μM | 24650643 |
| BALB/3T3 | Growth Inhibition Assay | IC50=0.5 μM | 24631190 | |||
| 26-L5 | Function Assay | 6 h | Antiinvasive activity | 24592993 | ||
| CEM/ADR5000 | Cytotoxic Assay | DMSO | Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein with IC50 of 23.27 μM | 24561670 | ||
| CCRF-CEM | Cytotoxic Assay | DMSO | IC50=0.009 μM | 24561670 | ||
| V79 | Cytotoxic Assay | 1.10 μM | 72 h | DMSO | IC50=0.24 μM | 24530030 |
| MX1 | Cytotoxic Assay | 1.10 μM | 72 h | DMSO | IC50=0.5 μM | 24530030 |
| L929 | Cytotoxic Assay | 1.10 μM | 72 h | DMSO | IC50=0.16 μM | 24530030 |
| ME180 | Cytotoxic Assay | 48 h | IC50=0.39 μM | 24487188 | ||
| MGC803 | Cytotoxic Assay | 72 h | IC50=0.17 μM | 24370114 | ||
| CHP100 | Cytotoxic Assay | 72 h | IC50=0.79 μM | 24251417 | ||
| Bel7402 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.5782 μM | 24211639 | |
| SGC7901 | Cytotoxic Assay | IC50=0.011 μM | 24195466 | |||
| MKN28 | Growth Inhibition Assay | 48 h | GI50=0.24 μM | 24184076 | ||
| Caco2 | Growth Inhibition Assay | 48 h | GI50=0.32 μM | 24184076 | ||
| MDA-MB-468 | Growth Inhibition Assay | 10 μM | 72 h | GI50=0.085 μM | 24163729 | |
| Caco2 | Cytotoxic Assay | 40 μM | 24 h | Cytotoxicity | 24099994 | |
| U2OS | Growth Inhibition Assay | 72 h | IC50=0.3 μM | 24095089 | ||
| OVCAR8 | Growth Inhibition Assay | 20 μM | 72 h | Antiproliferative activity | 24095089 | |
| LNcaP | Function Assay | 3 μM | 24 h | Up-regulation of p53 expression | 24095089 | |
| LNcaP | Function Assay | 3 μM | 24 h | Increase of cleaved caspase-9 level | 24095089 | |
| Caov3 | Growth Inhibition Assay | 72 h | IC50=0.1 μM | 24095089 | ||
| AS49-RAW | Cytotoxic Assay | 100 μM | 48 h | IC50=32.78 μM | 24077528 | |
| MDA-MB-435 | Cytotoxic Assay | 100 μM | 48 h | IC50=0.15 μM | 24028446 | |
| HUVEC | Function Assay | 5 μM | 2 h | Cellular uptake | 24028446 | |
| MRC5 | Growth Inhibition Assay | 72 h | IC50=0.1 μM | 24021462 | ||
| HepG2 | Function Assay | 40 μg/mL | 48 h | DMSO | Inhibition of TRK with IC50 of 0.0025 μM | 24013411 |
| HUVEC | Cytotoxic Assay | 48 h | IC50=0.0807 μM | 24012378 | ||
| KB/HeLa | Cytotoxic Assay | 45 h | EC50=0.25 μM | 23988351 | ||
| MDA-MB-231 | Function Assay | 5 μM | 24 h | Antioxidant activity assessed as intramitochondrial ROS level | 23973213 | |
| MDA-MB-231 | Function Assay | 5 μM | 24 h | Antioxidant activity assessed as intracellular malonyldialdehyde level | 23973213 | |
| MDA-MB-231 | Function Assay | 5 μM | 24 h | Cellular uptake | 23973213 | |
| MCF7 | Function Assay | 5 μM | 24 h | Cellular uptake | 23973213 | |
| MCF7 | Function Assay | 5 μM | 24 h | Antioxidant activity assessed as intracellular malonyldialdehyde level | 23973213 | |
| MCF7 | Function Assay | 5 μM | 24 h | Cellular uptake | 23973213 | |
| MCF7 | Function Assay | 5 μM | 24 h | Antioxidant activity assessed as intramitochondrial ROS level | 23973213 | |
| H9c2 | Function Assay | 5 μM | 24 h | Cellular uptake | 23973213 | |
| H9c2 | Function Assay | 5 μM | 24 h | Antioxidant activity assessed as intracellular ROS level | 23973213 | |
| H9c2 | Function Assay | 5 μM | 24 h | Antioxidant activity assessed as intracellular malonyldialdehyde level | 23973213 | |
| H9c2 | Function Assay | 5 μM | 24 h | Antioxidant activity assessed as intramitochondrial ROS level | 23973213 | |
| HaCaT | Growth Inhibition Assay | 25 μg/mL | 48 h | TGI50=0.4 μM | 23876338 | |
| UO31 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.49 μM | 23871905 | |
| UACC257 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.14 μM | 23871905 | |
| U251 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.04 μM | 23871905 | |
| TK10 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.18 μM | 23871905 | |
| SR | Cytotoxic Assay | 100 μM | 48 h | GI50=0.03 μM | 23871905 | |
| SNB75 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.07 μM | 23871905 | |
| SNB19 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.04 μM | 23871905 | |
| SN12C | Cytotoxic Assay | 100 μM | 48 h | GI50=0.07 μM | 23871905 | |
| SK-MEL-28 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.21 μM | 23871905 | |
| SF539 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.12 μM | 23871905 | |
| RXF393 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.1 μM | 23871905 | |
| PRMI8226 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.08 μM | 23871905 | |
| OVCAR-8 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.1 μM | 23871905 | |
| OVCAR5 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.41 μM | 23871905 | |
| OVCAR4 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.37 μM | 23871905 | |
| NCI-H522 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.03 μM | 23871905 | |
| NCI-H322M | Cytotoxic Assay | 100 μM | 48 h | GI50=0.54 μM | 23871905 | |
| NCI-H226 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.05 μM | 23871905 | |
| MALME-3M | Cytotoxic Assay | 100 μM | 48 h | GI50=0.12 μM | 23871905 | |
| M14 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.18 μM | 23871905 | |
| LOXIMVI | Cytotoxic Assay | 100 μM | 48 h | GI50=0.07 μM | 23871905 | |
| KM12 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.27 μM | 23871905 | |
| IGROVI | Cytotoxic Assay | 100 μM | 48 h | GI50=0.17 μM | 23871905 | |
| HOP92 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.1 μM | 23871905 | |
| HCC2998 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.26 μM | 23871905 | |
| EKVX | Cytotoxic Assay | 100 μM | 48 h | GI50=0.41 μM | 23871905 | |
| Caki1 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.95 μM | 23871905 | |
| ACHN | Cytotoxic Assay | 100 μM | 48 h | GI50=0.08 μM | 23871905 | |
| 786-0 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.13 μM | 23871905 | |
| HOP62 | Growth Inhibition Assay | 100 μM | 48 h | GI50=0.14 μM | 23849207 | |
| Gurav | Growth Inhibition Assay | 100 μM | 48 h | GI50=0.17 μM | 23849207 | |
| DWD | Growth Inhibition Assay | 100 μM | 48 h | GI50=0.1 μM | 23849207 | |
| COLO205 | Growth Inhibition Assay | 100 μM | 48 h | GI50=0.14 μM | 23849207 | |
| LS180 | Cytotoxic Assay | 72 h | DMSO | IC50=0.04 μM | 23827179 | |
| 786 | Cytotoxic Assay | 48 h | DMSO | IC50=0.33 μM | 23810282 | |
| HGF | Cytotoxic Assay | 25 mM | 24 h | IC50=0.5 μM | 23802716 | |
| C643 | Cytotoxic Assay | 25 mM | 24 h | IC50=0.07 μM | 23802716 | |
| B16F10 | Cytotoxic Assay | 48 h | DMSO | IC50=0.072 μM | 23777898 | |
| JURKAT-TALL | Cytotoxic Assay | 48 h | IC50=0.0096 μM | 23673218 | ||
| U266 | Cytotoxic Assay | 72 h | IC50=0.67 μM | 23600925 | ||
| SW872 | Cytotoxic Assay | 72 h | IC50=0.14 μM | 23600925 | ||
| SK-UT-1 | Cytotoxic Assay | 72 h | IC50=0.076 μM | 23600925 | ||
| SK-ES-1 | Cytotoxic Assay | 72 h | IC50=0.042 μM | 23600925 | ||
| SK-BR-3 | Cytotoxic Assay | 72 h | IC50=0.09 μM | 23600925 | ||
| NCI-H929 | Cytotoxic Assay | 72 h | IC50=0.065 μM | 23600925 | ||
| MNNG-HOS | Cytotoxic Assay | 72 h | IC50=0.59 μM | 23600925 | ||
| MDA-MB-436 | Cytotoxic Assay | 72 h | IC50=0.1 μM | 23600925 | ||
| A673 | Apoptosis Assay | 24 h | DMSO | Induction of apoptosis assessed as caspase-3 activation with EC50 of 0.39 μM | 23600925 | |
| A673 | Cytotoxic Assay | 72 h | Cytotoxicity against human A673 cells after 72 hrs by resazurin/resorufin-based fluorescence assay with IC50 of 0.17 μM | 23600925 | ||
| MA9.3 | Cytotoxic Assay | 100 μM | 48 h | IC50=0.086 μM | 23578690 | |
| SK-MEL | Cytotoxic Assay | 48 h | DMSO | IC50=1.5 μM | 23547843 | |
| HeLa | Cytotoxic Assay | 1 μM | 72 h | IC50=0.01 μM | 23470139 | |
| POS1 | Growth Inhibition Assay | 72 h | IC50=0.043 μM | 23360521 | ||
| OSRGA | Growth Inhibition Assay | 72 h | IC50=0.093 μM | 23360521 | ||
| L929 | Growth Inhibition Assay | 72 h | IC50=0.161 μM | 23360521 | ||
| AT6-1 | Growth Inhibition Assay | 72 h | IC50=2 μM | 23360521 | ||
| WHCO1 | Cytotoxic Assay | 48 h | DMSO | IC50=0.5 μM | 23353747 | |
| MOLT4 | Cytotoxic Assay | 48 h | DMSO | IC50=0.02 μM | 23218718 | |
| MGC803 | Growth Inhibition Assay | 20 μM | 72 h | DMSO | IC50=0.7 μM | 23124210 |
| Bcap37 | Growth Inhibition Assay | 20 μM | 72 h | DMSO | IC50=1.28 μM | 23124210 |
| HL60/Vinc | Cytotoxic Assay | 100 μg/mL | 72 h | DMSO | Cytotoxicity against human HL60/Vinc cells with IC50 of 0.91 μM | 23079523 |
| BALB/3T3 | Cytotoxic Assay | 100 μg/mL | 72 h | DMSO | IC50=1.91 μM | 23079523 |
| MG63 | Cytotoxic Assay | IC50=2.7 μM | 23043498 | |||
| HL60/A | Cytotoxic Assay | 18 h | IC50=6.7 μM | 22985027 | ||
| A549 | Cytotoxic Assay | IC50=0.001 μM | 22951040 | |||
| MESSA/DX5 | Growth Inhibition Assay | 100 μg/mL | 72 h | DMSO | IC50=0.25 μM | 22944121 |
| SKLU1 | Cytotoxic Assay | 48 h | DMSO | IC50=0.0067 μM | 22858298 | |
| HCT15 | Cytotoxic Assay | 48 h | DMSO | IC50=0.005 μM | 22858298 | |
| U2OS | Cytotoxic Assay | 4 μM | 72 h | DMSO | IC50=3.4 μM | 22749279 |
| B16 | 48 h | IC50=0.03 μM | 22668451 | |||
| MKN45 | Cytotoxic Assay | 48 h | DMSO | IC50=0.168 μM | 22647723 | |
| HMEC1 | Cytotoxic Assay | 250 μg/mL | 72 h | IC50=0.06 μM | 22616554 | |
| BMDM | Cytotoxic Assay | 250 μg/mL | 72 h | IC50=4.6 μM | 22616554 | |
| J774A.1 | Cytotoxic Assay | 72 h | DMSO | IC50=0.02 μM | 22608675 | |
| WI38 | Growth Inhibition Assay | 100 μM | 72 h | DMSO | IC50=0.04 μM | 22555152 |
| SW620 | Growth Inhibition Assay | 100 μM | 72 h | DMSO | IC50=0.04 μM | 22555152 |
| NCI/ADR | Growth Inhibition Assay | 25 μg/mL | 48 h | IC50=13.5 μM | 22537680 | |
| 786-0 | Growth Inhibition Assay | 25 μg/mL | 48 h | IC50=2.1 μM | 22537680 | |
| SMMC7721 | Cytotoxic Assay | 500 μM | 48 h | DMSO | IC50=0.37 μM | 22537362 |
| KB/VCR | Cytotoxic Assay | 500 μM | 48 h | DMSO | IC50=0.45 μM | 22537362 |
| U87MG | Growth Inhibition Assay | 2 μM | 48 h | IC50=0.79 μM | 22515366 | |
| NCI-H290 | Growth Inhibition Assay | 2 μM | 48 h | IC50=0.32 μM | 22515366 | |
| LLC | Growth Inhibition Assay | 48 h | IC50=0.207 μM | 22515366 | ||
| XF498 | Cytotoxic Assay | 48 h | IC50=0.015 μM | 22483395 | ||
| SK-MEL-2 | Cytotoxic Assay | 48 h | IC50=0.002 μM | 22483395 | ||
| K562/A02 | Growth Inhibition Assay | 72 h | DMSO | Antiproliferative activity against multidrug-resistant human K562/A02 cells overexpressing p-glycoprotein with IC50 of 46.69 μM | 22450134 | |
| HuH7 | Growth Inhibition Assay | 25 ng/mL | 72 h | DMSO | Antiproliferative activity assessed as inhibition of BrdU incorporation | 22409771 |
| HuH7 | Function Assay | 25 ng/mL | 72 h | DMSO | Induction of senescence assessed as increase in senescence associated beta-galactosidase activity | 22409771 |
| SK-N-SH | Cytotoxic Assay | 48 h | IC50=0.97 μM | 22386528 | ||
| SiHa | Growth Inhibition Assay | GI50=0.14 μM | 22361684 | |||
| B16 | Cytotoxic Assay | 72 h | DMSO | IC50=0.1 μM | 22330634 | |
| SKOV3 | Function Assay | 5 μM | 1 h | DMSO | Cellular uptake in doxorubicin-resistant human SKOV3 cells | 22276998 |
| SKOV3 | Function Assay | 5 μM | 1 h | DMSO | Drug uptake in doxorubicin-resistant human SKOV3 cell nucleu | 22276998 |
| LNcaP | Apoptosis Assay | 20 μg/mL | 24 h | water | Induction of apoptosis assessed as increase in caspase 3/7 activation | 22264758 |
| PC3M | Cytotoxic Assay | 72 h | DMSO | IC50=0.24 μM | 22264149 | |
| QGY7701 | Cytotoxic Assay | 24 h | DMSO | IC50=8.65 μM | 22182926 | |
| A375-C5 | Growth Inhibition Assay | 48 h | DMSO | GI50=0.0915 μM | 22177409 | |
| RAW264.7 | Cytotoxic Assay | 10 μM | 24 h | DMSO | Cytotoxicity assessed as cell viability | 22129061 |
| SKOV3 | Growth Inhibition Assay | 50 μM | 72 h | DMSO | Antiproliferative activity against human SKOV3 cells overexpressing c-Src | 22119472 |
| BGC823 | Cytotoxic Assay | 96 h | DMSO | IC50=0.98 μM | 22070654 | |
| HCT8 | Cytotoxic Assay | 5 μg/mL | 72 h | DMSO | IC50=0.02 μM | 22000949 |
| MCF7 | Function Assay | 50 μg/mL | 48 h | DMSO | Reduction in AP-2 gamma mRNA expression | 22000946 |
| MCF7 | Function Assay | 50 μg/mL | 48 h | DMSO | Reduction in CYP19 mRNA expression | 22000946 |
| MCF7 | Function Assay | 50 μg/mL | 48 h | DMSO | Reduction in VEGF mRNA expression | 22000946 |
| Neuro2a | Cytotoxic Assay | 72 h | IC50=1.2 μM | 21996519 | ||
| PC3 | Growth Inhibition Assay | 48 h | GI50=0.09 μM | 21875046 | ||
| AGS | Growth Inhibition Assay | 48 h | GI50=0.01 μM | 21875046 | ||
| BT20 | Growth Inhibition Assay | 10 μM | 72 h | Antiproliferative activity | 21852023 | |
| K562/A02 | Cytotoxic Assay | 48 h | DMSO | IC50=17.84 μM | 21843940 | |
| Ca9-22 | Cytotoxic Assay | 72 h | DMSO | IC50=0.26 μM | 21800859 | |
| SH-SY5Y | Cytotoxic Assay | 48 h | IC50=0.5 μM | 21797280 | ||
| LAMA-84 | Cytotoxic Assay | 48 h | IC50=0.74 μM | 21797280 | ||
| A2780/ADR | Cytotoxic Assay | IC50=0.194 μM | 21774499 | |||
| A2780 | Cytotoxic Assay | IC50=0.0012 μM | 21774499 | |||
| NCI-H187 | Cytotoxic Assay | 72 h | IC50=0.03 μM | 21741833 | ||
| KATO | Cytotoxic Assay | 72 h | IC50=0.33 μM | 21741833 | ||
| ChaGo | Cytotoxic Assay | 72 h | IC50=0.83 μM | 21741833 | ||
| BT474 | Cytotoxic Assay | 72 h | IC50=0.07 μM | 21741833 | ||
| HFF | Cytotoxic Assay | 72 h | CC50=0.03 μM | 21741131 | ||
| Gurav | Cytotoxic Assay | 100 μM | 48 h | DMSO | GI50<0.1 μM | 21737288 |
| ZR-75B | Cytotoxic Assay | 72 h | IC50=2.02 μM | 21721528 | ||
| ZR-75B | Cytotoxic Assay | 72 h | IC50=0.04 μM | 21721528 | ||
| SW620 | Cytotoxic Assay | 72 h | IC50=0.01 μM | 21721528 | ||
| NIH3T3 | Cytotoxic Assay | 72 h | IC50=0.05 μM | 21721528 | ||
| NCI/ADR-RES | Cytotoxic Assay | 72 h | IC50=9.3 μM | 21721528 | ||
| LLC-PK1 | Cytotoxic Assay | 72 h | IC50=0.2 μM | 21721528 | ||
| KBV1 | Cytotoxic Assay | 72 h | IC50=4.7 μM | 21721528 | ||
| KB3-1 | Cytotoxic Assay | 72 h | IC50=0.02 μM | 21721528 | ||
| HEK293 | Cytotoxic Assay | 72 h | IC50=0.42 μM | 21721528 | ||
| HEK293 | Cytotoxic Assay | 72 h | IC50=0.01 μM | 21721528 | ||
| Ew36 | Cytotoxic Assay | 72 h | IC50=0.01 μM | 21721528 | ||
| MG63 | Growth Inhibition Assay | 72 h | IC50=2.8 μM | 21721519 | ||
| PC3 | Cytotoxic Assay | 160 μg/mL | 5 d | DMSO | GI50=0.021 μM | 21711054 |
| NCI-H23 | Cytotoxic Assay | 160 μg/mL | 5 d | DMSO | GI50=0.005 μM | 21711054 |
| Hs578 | Cytotoxic Assay | 160 μg/mL | 5 d | DMSO | GI50=0.006 μM | 21711054 |
| BT549 | Cytotoxic Assay | 160 μg/mL | 5 d | DMSO | GI50=0.01 μM | 21711054 |
| HOP62 | Cytotoxic Assay | 24 h | GI50=0.14 μM | 21676506 | ||
| SW480 | Growth Inhibition Assay | 48 h | IC50=0.06 μM | 21641694 | ||
| S180 | Growth Inhibition Assay | 48 h | IC50=29.2 μM | 21620529 | ||
| H22 | Growth Inhibition Assay | 48 h | IC50=36.51 μM | 21620529 | ||
| P388D1 | Growth Inhibition Assay | IC50=0.338 μM | 21570750 | |||
| KATOIII | Growth Inhibition Assay | IC50=4.38 μM | 21570750 | |||
| SK-MEL-28 | Growth Inhibition Assay | 25 nM | 24 h | DMSO | IC50=0.6 μM | 21553829 |
| SF295 | Growth Inhibition Assay | 25 nM | 24 h | DMSO | IC50=4.4 μM | 21553829 |
| A375 | Growth Inhibition Assay | 72 h | PBS | IC50=0.13 μM | 21496972 | |
| HCT8 | Cytotoxic Assay | 0.58 μg/mL | 69 h | DMSO | IC50=0.02 μM | 21381705 |
| NCI-N87 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.4198 μM | 21296467 | |
| HUVEC | Growth Inhibition Assay | 96 h | DMSO | IC50=0.0303 μM | 21296467 | |
| HepG2 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.019 μM | 21296467 | |
| CCRF | Growth Inhibition Assay | 96 h | DMSO | IC50=0.0375 μM | 21296467 | |
| IMR90 | Cytotoxic Assay | 48 h | DMSO | IC50=0.59 μM | 21215623 | |
| Molt4/C8 | Cytotoxic Assay | 72 h | DMSO | IC50=0.2 μM | 21144624 | |
| CEM | Cytotoxic Assay | 72 h | DMSO | IC50=0.06 μM | 21144624 | |
| MDA435 | Cytotoxic Assay | 10 μM | 72 h | DMSO | IC50=0.0035 μM | 21142180 |
| MDA231 | Cytotoxic Assay | 10 μM | 72 h | DMSO | IC50=4.7x10-5 μM | 21142180 |
| HL60R | Cytotoxic Assay | 10 μM | 72 h | DMSO | IC50=0.99 μM | 21142180 |
| C33A | Cytotoxic Assay | 100 μg/mL | 48 h | IC50=0.82 μM | 21071221 | |
| MKN45 | Growth Inhibition Assay | 72 h | IC50=0.00019 μM | 21067930 | ||
| KB | Growth Inhibition Assay | 72 h | IC50=0.00023 μM | 21067930 | ||
| H460 | Growth Inhibition Assay | 72 h | IC50=0.00038 μM | 21067930 | ||
| KB8.5 | Cytotoxic Assay | 50 μM | 72 h | DMSO | IC50=3.3 μM | 21035234 |
| BJ | Cytotoxic Assay | 48 h | DMSO | IC50=2.33 μM | 20931970 | |
| ARPE19 | Cytotoxic Assay | 48 h | DMSO | IC50=0.76 μM | 20931970 | |
| THP1 | Cytotoxic Assay | 72 h | DMSO | IC50=0.008 μM | 20833057 | |
| SiHa | Cytotoxic Assay | 4 μM | 24 h | GI50=0.17 μM | 20732817 | |
| DWD | Cytotoxic Assay | 4 μM | 24 h | GI50=0.1 μM | 20732817 | |
| SKOV3 | Cytotoxic Assay | IC50=0.001 μM | 20719504 | |||
| Hep3B | Cytotoxic Assay | 11 d | IC50=0.14 μM | 20718475 | ||
| COLO205 | Cytotoxic Assay | 48 h | DMSO | GI50=0.1 μM | 20673627 | |
| HCT-15 | Cytotoxic Assay | IC50=0.038 μM | 20594848 | |||
| NUGC3 | Cytotoxic Assay | GI50=0.202 μM | 20579876 | |||
| CCRF-CEM | Growth Inhibition Assay | 48 h | GI50=0.02 μM | 20570145 | ||
| HAEC | Cytotoxic Assay | 100 μM | 24 h | DMSO | IC50=13 μM | 20547797 |
| PAXF1657L | Cytotoxic Assay | 10 μM | 24 h | IC50=0.052 μM | 20545334 | |
| MEXF462NL | Cytotoxic Assay | 10 μM | 24 h | IC50=0.052 μM | 20545334 | |
| MAXF401NL | Cytotoxic Assay | 10 μM | 24 h | IC50=0.052 μM | 20545334 | |
| GXF251L | Cytotoxic Assay | 10 μM | 24 h | IC50=0.052 μM | 20545334 | |
| CEM/ADR5000 | Function Assay | 1 μg/mL | 6 h | Increase in ROS generation | 20527917 | |
| CEM/ADR5000 | Apoptosis Assay | 1 μg/mL | 24 h | Induction of apoptosis | 20527917 | |
| PCO3 | Cytotoxic Assay | 250 μg/mL | 48 h | GI50=0.17 μM | 20413188 | |
| OVCAR-3 | Cytotoxic Assay | 250 μg/mL | 48 h | GI50=0.07 μM | 20413188 | |
| NCI/ADR | Cytotoxic Assay | 250 μg/mL | 48 h | GI50=5.99 μM | 20413188 | |
| 3T3 | Cytotoxic Assay | 10 μM | 48 h | IC50=3.7 μM | 20405844 | |
| HBI10A | Cytotoxic Assay | CC50<0.3 μM | 20363140 | |||
| U937 | Cytotoxic Assay | 72 h | IC50=0.00445 μM | 20356655 | ||
| NB-1 | Cytotoxic Assay | 72 h | IC50=0.00515 μM | 20356655 | ||
| K562 | Cytotoxic Assay | 72 h | IC50=0.00612 μM | 20356655 | ||
| HL60 | Cytotoxic Assay | 72 h | IC50=0.00113 μM | 20356655 | ||
| GOTO | Cytotoxic Assay | 72 h | IC50=0.00473 μM | 20356655 | ||
| SK-N-MC | Cytotoxic Assay | 72 h | IC50=0.12 μM | 20303768 | ||
| U87MG | Cytotoxic Assay | 48 h | IC50=0.018 μM | 20210346 | ||
| SKHEP1 | Cytotoxic Assay | 48 h | IC50=0.01 μM | 20210346 | ||
| MIAPaCa2 | Cytotoxic Assay | 100 μM | 72 h | IC50=0.01 μM | 20207049 | |
| SKHep | Growth Inhibition Assay | 48 h | DMSO | IC50=0.09 μM | 20171108 | |
| MESSA/DX5 | Function Assay | 50 μM | 2 h | water | Induction of DNA damage assessed as increase in comet-tail length | 20151639 |
| MESSA | Function Assay | 25 μM | 2 h | water | Cellular uptake | 20151639 |
| MESSA | Function Assay | 50 μM | 2 h | water | Induction of DNA damage assessed as increase in comet-tail length | 20151639 |
| MCF10A | Cytotoxic Assay | 40 μM | 48 h | DMSO | IC50=0.18 μM | 20064676 |
| IMR32 | Growth Inhibition Assay | 48 h | DMSO | IC50=1.7 μM | 19939522 | |
| MOLT3 | Cytotoxic Assay | IC50=0.04 μM | 19824618 | |||
| HuCCa1 | Cytotoxic Assay | 4 d | IC50=0.64 μM | 19824618 | ||
| HCT15 | Cytotoxic Assay | IC50=0.037 μM | 19819696 | |||
| MDA-MB-453 | Cytotoxic Assay | 0.58 μg/mL | 69 h | DMSO | IC50=0.12 μM | 19788290 |
| HL60/MX2 | Cytotoxic Assay | 48 h | DMSO | IC50=8.046 μM | 19743858 | |
| 2008/P | Cytotoxic Assay | 5 d | DMSO | IC50=0.063 μM | 19725578 | |
| 2008/MRP1 | Cytotoxic Assay | 5 d | DMSO | IC50=0.577 μM | 19725578 | |
| Colon 26-L5 | Cytotoxic Assay | 72 h | DMSO | IC50=3.12 μM | 19689125 | |
| B16-BL6 | Cytotoxic Assay | 72 h | DMSO | IC50=3.07 μM | 19689125 | |
| KB | Cytotoxic Assay | 72 h | DMSO | IC50=0.001 μM | 19655762 | |
| HCT116 | Cytotoxic Assay | 72 h | DMSO | IC50=0.006 μM | 19655762 | |
| U251 | Growth Inhibition Assay | 72 h | DMSO | IC50=0.6 μM | 19632833 | |
| OS-RC2 | Growth Inhibition Assay | 72 h | DMSO | IC50=5.4 μM | 19632833 | |
| MOLT4 | Growth Inhibition Assay | 72 h | DMSO | IC50=0.002 μM | 19632833 | |
| L78 | Growth Inhibition Assay | 72 h | DMSO | IC50=2.4 μM | 19632833 | |
| IMR90 | Growth Inhibition Assay | 72 h | DMSO | IC50=1 μM | 19632833 | |
| SK-N-SH | Apoptosis Assay | 5 μM | Induction of apoptosis assessed as caspase 3 activity | 19631549 | ||
| SK-N-SH | Apoptosis Assay | 5 μM | Induction of apoptosis at 0.5 to 5 uM | 19631549 | ||
| SNU1 | Cytotoxic Assay | IC50=4 μM | 19585998 | |||
| MDA-MB-231 | Growth Inhibition Assay | 200 μM | 48 h | DMSO | Antitumor activity against human estrogen receptor deficient MDA-MB-231 cells with GI50 of 0.01086 μM | 19428155 |
| U251 | Function Assay | 1 μM | 16 h | DMSO | Inhibition of HIF1 activation in human U251 cells stably transfected in pGL2-TK-HRE plasmid with EC50 of 0.12 μM | 19405508 |
| SKOV3 | Growth Inhibition Assay | GI50=0.021 μM | 19394218 | |||
| MESSA | Growth Inhibition Assay | GI50=0.0051 μM | 19394218 | |||
| A549 | Growth Inhibition Assay | GI50=0.003 μM | 19394218 | |||
| A431 | Growth Inhibition Assay | GI50=0.0012 μM | 19394218 | |||
| PA1 | Cytotoxic Assay | 10 μM | 72 h | IC50=0.63 μM | 19361894 | |
| HBL100 | Cytotoxic Assay | 10 μM | 72 h | IC50=0.24 μM | 19361894 | |
| ECV304 | Cytotoxic Assay | 10 μM | 72 h | Cytotoxicity | 19361894 | |
| WTK1 | Function Assay | 0.1 μM | 72 h | Cell cycle arrest in human WTK1 cells expressing p53 M237I mutant assessed as accumulation at sub-G0/G1 phase | 19349174 | |
| WTK1 | Function Assay | 25 μM | 8 h | Induction of p53 transcriptional activity in human WTK1 cells expressing p53 M237I mutant assessed as p21-Cip1/Waf1 expression | 19349174 | |
| WTK1 | Function Assay | 25 μM | 8 h | Induction of p53 phosphorylation at Ser15 in human WTK1 cells expressing p53 M237I mutant | 19349174 | |
| WTK1 | Function Assay | 0.1 μM | 8 h | Induction of p53 transcriptional activity in human WTK1 cells expressing p53 M237I mutant assessed as p21-Cip1/Waf1 expression | 19349174 | |
| WTK1 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in human WTK1 cells expressing p53 M237I mutant assessed as increase in PARP cleavage | 19349174 | |
| WTK1 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in human WTK1 cells expressing p53 M237I mutant assessed as decrease in pro-caspase 3 level | 19349174 | |
| WTK1 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in human WTK1 cells expressing p53 M237I mutant assessed as increase in cleaved caspase 3 level | 19349174 | |
| WTK1 | Function Assay | 0.1 μM | 8 h | Induction of p53 phosphorylation at Ser15 in human WTK1 cells expressing p53 M237I mutant | 19349174 | |
| TK6 | Function Assay | 25 μM | 8 h | Induction of p53 transcriptional activity in human TK6 cells expressing wild type p53 assessed as p21-Cip1/Waf1 expression | 19349174 | |
| TK6 | Function Assay | 25 μM | 8 h | Induction of p53 phosphorylation at Ser15 in human TK6 cells expressing wild type p53 | 19349174 | |
| TK6 | Function Assay | 0.1 μM | 72 h | Cell cycle arrest in human TK6 cells expressing wild type p53 assessed as accumulation at sub-G0/G1 phase | 19349174 | |
| TK6 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in human TK6 cells expressing wild type p53 assessed as increase in PARP cleavage | 19349174 | |
| TK6 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in human TK6 cells expressing wild type p53 assessed as decrease in pro-caspase 3 level | 19349174 | |
| TK6 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in human TK6 cells expressing wild type p53 assessed as increase in cleaved caspase 3 level | 19349174 | |
| TK6 | Function Assay | 0.1 μM | 8 h | Induction of p53 transcriptional activity in human TK6 cells expressing wild type p53 assessed as p21-Cip1/Waf1 expression | 19349174 | |
| TK6 | Function Assay | 0.1 μM | 8 h | Induction of p53 phosphorylation at Ser15 in human TK6 cells expressing wild type p53 | 19349174 | |
| NH32 | Growth Inhibition Assay | 0.1 μM | 72 h | Cell cycle arrest in p53 deficient human NH32 cells assessed as accumulation at sub-G0/G1 phase | 19349174 | |
| NH32 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in p53 deficient human NH32 cells assessed as increase in PARP cleavage | 19349174 | |
| NH32 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in p53 deficient human NH32 cells assessed as decrease in pro-caspase 3 level | 19349174 | |
| NH32 | Apoptosis Assay | 0.1 μM | 8 h | Induction of apoptosis in p53 deficient human NH32 cells assessed as increase in cleaved caspase 3 level | 19349174 | |
| SMMC-7541 | Cytotoxic Assay | 72 h | IC50=0.0037 μM | 19285863 | ||
| T47D | Apoptosis Assay | 10 μM | 48 h | DMSO | Induction of apoptosis assessed as caspase activation with EC50 of 0.57 μM | 19282188 |
| SNU398 | Apoptosis Assay | 10 μM | 48 h | DMSO | Induction of apoptosis assessed as caspase activation with EC50 of 0.39 μM | 19282188 |
| MEF | Cytotoxic Assay | 72 h | IC50=3.4 μM | 19186946 | ||
| Hs888Lu | Cytotoxic Assay | 72 h | IC50=1.4 μM | 19186946 | ||
| HL60 | Cytotoxic Assay | 100 μM | 72 h | DMSO | IC50=0.018 μM | 19136263 |
| A2780/DX3 | Function Assay | 10 μM | 2 h | saline | Reversal of P-gp 170-mediated multidrug resistance assessed as increase in intracellular doxorubicin accumulation | 19093883 |
| XF498 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.16 μM | 19053767 | |
| MT4 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.003 μM | 19053767 | |
| HT-29 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.002 μM | 19053767 | |
| HT-29 | Cytotoxic Assay | 72 h | DMSO | IC50=0.018 μM | 19028425 | |
| Bel7402 | Cytotoxic Assay | 72 h | DMSO | IC50=0.021 μM | 19028425 | |
| DU145 | Cytotoxic Assay | 25 μg/mL | 72 h | IC50=0.0039 μM | 18829316 | |
| MRC5 | Cytotoxic Assay | 72 h | IC50=0.1 μM | 18783950 | ||
| Jurkat | Cytotoxic Assay | 72 h | IC50=0.03 μM | 18783950 | ||
| AW8507 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.17 μM | 18657979 | |
| AW13516 | Cytotoxic Assay | 100 μM | 48 h | GI50=0.1 μM | 18657979 | |
| SK-MEL-2 | Growth Inhibition Assay | 72 h | GI50=0.11 μM | 18585035 | ||
| L1210 | Function Assay | 0.5 μg/mL | 12 h | water | Cell cycle arrest in mouse L1210 cells by accumulation at G2/M phase | 18508273 |
| LLC | Cytotoxic Assay | 72 h | DMSO | IC50=0.01 μM | 18440233 | |
| Colon 26-L5 | Cytotoxic Assay | 72 h | DMSO | IC50=0.01 μM | 18440233 | |
| MCF7/DX | Cytotoxic Assay | 24 h | water | Cytotoxicity against human doxorubicin-resistant MCF7/Dx cells with IC50 of 5.3 μM | 18429610 | |
| Caco2 | Function Assay | 50 nM | 48 h | water | Decrease in cyclin A expression | 18429610 |
| SNU638 | Cytotoxic Assay | 72 h | DMSO | IC50=0.052 μM | 18321715 | |
| HT1080 | Cytotoxic Assay | 72 h | DMSO | IC50=0.022 μM | 18321715 | |
| Hep2 | Cytotoxic Assay | 24 h | DMSO | IC50=0.42 μM | 18281125 | |
| A375 | Cytotoxic Assay | 24 h | DMSO | IC50=0.01 μM | 18281125 | |
| K/VP.5 | Growth Inhibition Assay | 72 h | DMSO | Growth inhibition of human K/VP.5 cells with IC50 of 0.41 μM | 18258442 | |
| PC3M | Growth Inhibition Assay | 72 h | DMSO | IC50=1.11 μM | 18247573 | |
| SJSA1 | Cytotoxic Assay | 1 μM | 6 h | Cytotoxicity against human SJSA1 cells expressing GRP78 with IC50 of 0.0062 μM | 18243696 | |
| HepG2 | Cytotoxic Assay | 100 μM | 72 h | IC50=0.07 μM | 18181575 | |
| U373MG | Growth Inhibition Assay | 24 h | DMSO | Growth inhibition of human U373MG cells containing UhiCE expressing plasmid with IC50 of 0.19953 μM | 18173233 | |
| U373MG | Growth Inhibition Assay | 24 h | DMSO | Growth inhibition of human U373MG cells containing UhCE1 expressing plasmid with IC50 of 0.15849 μM | 18173233 | |
| U373MG | Growth Inhibition Assay | 24 h | DMSO | Growth inhibition of human U373MG cells containing U373IRES plasmid with IC50 of 0.15849 μM | 18173233 | |
| SNU638 | Growth Inhibition Assay | 72 h | IC50=0.07 μM | 18063366 | ||
| SF268 | Growth Inhibition Assay | 72 h | DMSO | IC50=0.04 μM | 18052326 | |
| W301 | Growth Inhibition Assay | 50 mM | 48 h | DMSO | Growth inhibition of Saccharomyces cerevisiae W301 with IC50 of 10 μM | 18040043 |
| Daudi | Cytotoxic Assay | 100 μM | 96 h | Cytotoxicity against human Daudi cells under deem light with IC50 of 0.3 μM | 17993275 | |
| 2780.9S | Cytotoxic Assay | 100 μM | 96 h | Cytotoxicity against human 2780.9S cells under deem light with IC50 of 15 μM | 17993275 | |
| MCF7 | Growth Inhibition Assay | 100 μM | 72 h | DMSO | IC50=0.0007 μM | 17949859 |
| KB3.1 | Growth Inhibition Assay | 100 μM | 72 h | DMSO | IC50=0.0004 μM | 17949859 |
| WI38 | Growth Inhibition Assay | 100 μM | 72 h | IC50=0.1 μM | 17935309 | |
| MIAPaCa2 | Growth Inhibition Assay | 100 μM | 72 h | IC50=0.024 μM | 17935309 | |
| UACC257 | Growth Inhibition Assay | 48 h | IC50=0.20893 μM | 17696516 | ||
| RXF393 | Growth Inhibition Assay | 48 h | IC50=0.17783 μM | 17696516 | ||
| IGROVI | Growth Inhibition Assay | 48 h | IC50=0.10965 μM | 17696516 | ||
| BxPc3 | Growth Inhibition Assay | 3 h | IC50=0.31623 μM | 17696516 | ||
| PC3 | Function Assay | 20 nM | 72 h | Induction of senescence in human PC3 cells | 17658777 | |
| UO31 | Cytotoxic Assay | 72 h | IC50=0.1 μM | 17656091 | ||
| DLD1 | Cytotoxic Assay | 72 h | IC50=0.1 μM | 17656091 | ||
| UACC62 | Growth Inhibition Assay | 48 h | DMSO | GI50=0.094 μM | 17614292 | |
| LNcaP | Cytotoxic Assay | DMSO | ED50=0.04 μM | 17591444 | ||
| 1A9 | Cytotoxic Assay | DMSO | ED50=0.02 μM | 17591444 | ||
| ZR-751 | Cytotoxic Assay | 72 h | DMSO | IC50=0.04 μM | 17585747 | |
| BGC823 | Cytotoxic Assay | 48 h | IC50=0.35 μM | 17583953 | ||
| 2780AD | Growth Inhibition Assay | 10 μM | Growth inhibition of multidrug-resistant human 2780AD cells with IC50 of 0.298 μM | 17490878 | ||
| KB-VIN | Cytotoxic Assay | 72 h | DMSO | Cytotoxicity against human multidrug-resistant KB-VIN cells with EC50 of 1.7 μM | 17378530 | |
| MeVo | Cytotoxic Assay | 48 h | water | IC50=0.82 μM | 17375902 | |
| CEM/VM1 | Cytotoxic Assay | 72 h | DMSO | Cytotoxicity against teniposide-resistant CEM/VM1 cells with IC50 of 0.55 μM | 17323939 | |
| CEM/VLB100 | Cytotoxic Assay | 72 h | DMSO | Cytotoxicity against CEM/VLB100 cells with IC50 of 3.71 μM | 17323939 | |
| K562I/S9 | Growth Inhibition Assay | 72 h | DMSO | Antiproliferative activity against human multidrug-resistant K562i/S9 cells expressing Pgp with IC50 of 2 μM | 17276690 | |
| 2780AD | Cytotoxic Assay | 10 μM | Cytotoxicity againt multidrug-resistant human 2780AD cells with IC50 of 0.909 μM | 17239597 | ||
| TRAMP-C2H | Growth Inhibition Assay | 72 h | water | GI50=0.0158 μM | 17181166 | |
| TRAMP-C1A | Growth Inhibition Assay | 72 h | water | GI50=0.0204 μM | 17181166 | |
| K562 | Growth Inhibition Assay | 48 h | DMSO/methanol | IC50=0.01 μM | 17181164 | |
| MDA435/LCC6 | Growth Inhibition Assay | 4 d | DMSO | IC50=0.3 μM | 17154505 | |
| MDA-MB-231 | Cytotoxic Assay | 72 h | DMSO | IC50=0.03 μM | 17141923 | |
| A2780 | Growth Inhibition Assay | 1 μM | 4 d | DMSO | Inhibition of doxorubicin-resistant A2780 cell growth with IC50 of 0.061 μM | 17125254 |
| A2780 | Growth Inhibition Assay | 1 μM | 4 d | DMSO | Inhibition of A2780 cell growth with IC50 of 0.003 μM | 17125254 |
| Vero | Cytotoxic Assay | 24 h | DMSO | IC50=0.50119 μM | 17125253 | |
| SK-HEP-1 | Growth Inhibition Assay | 24 h | DMSO | IC50=0.05012 μM | 17125253 | |
| SHP77 | Growth Inhibition Assay | 24 h | DMSO | IC50=0.12589 μM | 17125253 | |
| H9c2 | Growth Inhibition Assay | 24 h | DMSO | IC50=0.01995 μM | 17125253 | |
| AGS | Cytotoxic Assay | IC50=0.31 μM | 17125240 | |||
| HA22T | Cytotoxic Assay | 72 h | DMSO | IC50=0.31 μM | 17107806 | |
| HL60/ADR | Cytotoxic Assay | 1 mM | 72 h | DMSO | Cytotoxicity against adriamycin-resistant HL60/ADR cells expressing MRP1 with IC50 of 2 μM | 17069934 |
| BC | Cytotoxic Assay | IC50=0.288 μM | 16933890 | |||
| Wil2-NS | Growth Inhibition Assay | 96 h | DMSO | IC50=0.02 μM | 16913700 | |
| G361 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.09 μM | 16913700 | |
| C8166 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.02 μM | 16913700 | |
| ACHN | Growth Inhibition Assay | 96 h | DMSO | IC50=0.001 μM | 16913700 | |
| 5637 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.02 μM | 16913700 | |
| MCF7 | Function Assay | 0.5 μg/mL | 24 h | DMSO | Inhibition of p53-mediated transactivation | 16862141 |
| VA13 | Growth Inhibition Assay | 48 h | DMSO | IC50=0.22 μM | 16499322 | |
| MESSA/DX5 | Cytotoxic Assay | Cytotoxicity against multidrug-resistant MES-SA/Dx5 cells with IC50 of 1.56 μM | 16169719 | |||
| MES-SA | Cytotoxic Assay | IC50=0.016 μM | 16169719 | |||
| HSG | Cytotoxic Assay | 24 h | CC50=1.9 μM | 15745812 | ||
| HSC-2 | Cytotoxic Assay | 24 h | CC50=0.68 μM | 15745812 | ||
| NCI-H69 | Cytotoxic Assay | 6 d | IC50=0.0113 μM | 15743178 | ||
| VA13 | Cytotoxic Assay | 48 h | DMSO | IC50=0.38 μM | 15730243 | |
| MeVo | Growth Inhibition Assay | 24 h | water | IC50=0.82 μM | 15715481 | |
| WI38 | Cytotoxic Assay | 48 h | DMSO | IC50=0.3 μM | 15620238 | |
| Rtx6 | Growth Inhibition Assay | 4 h | DMSO | Growth inhibition of ER expressing Rtx6 cells | 15588086 | |
| MEL-28 | Cytotoxic Assay | IC50=0.03 μM | 15225700 | |||
| Col2 | Cytotoxic Assay | 72 h | DMSO | IC50=0.52 μM | 15177438 | |
| U937/GTB | Cytotoxic Assay | 72 h | IC50=0.1 μM | 14987049 | ||
| RPMI8226 | Cytotoxic Assay | 72 h | IC50=0.1 μM | 14987049 | ||
| T47D | Cytotoxic Assay | 72 h | IC50=0.007 μM | 14980672 | ||
| MD-MB468 | Cytotoxic Assay | 72 h | IC50=0.007 μM | 14980672 | ||
| TRAMP-C2G | Growth Inhibition Assay | 72 h | IC50=0.0287 μM | 14971910 | ||
| TRAMP-C2D | Growth Inhibition Assay | 72 h | IC50=0.0465 μM | 14971910 | ||
| MDA-MB-435 | Growth Inhibition Assay | 4 h | DMSO | IC50=0.15 μM | 14971899 | |
| PANC-1 | Growth Inhibition Assay | 72 h | DMSO | GI50=3.5 μM | 14971893 | |
| MEL-28 | Growth Inhibition Assay | 72 h | DMSO | GI50=3.1 μM | 14971893 | |
| LOVO | Growth Inhibition Assay | 72 h | DMSO | GI50=0.01 μM | 14971893 | |
| LNcaP | Growth Inhibition Assay | 72 h | DMSO | GI50=0.02 μM | 14971893 | |
| IGROV | Growth Inhibition Assay | 72 h | DMSO | GI50=4.4 μM | 14971893 | |
| HeLa | Growth Inhibition Assay | 72 h | DMSO | GI50=0.01 μM | 14971893 | |
| DU145 | Growth Inhibition Assay | 72 h | DMSO | GI50=0.02 μM | 14971893 | |
| DuPRO | Cytotoxic Assay | EC50=1.8 μM | 14667208 | |||
| SF268 | Cytotoxic Assay | GI50=8.5 × 10-7 μg/mL | 14640532 | |||
| MCF7 | Cytotoxic Assay | GI50=8.0 × 10-7 μg/mL | 14640532 | |||
| H460 | Cytotoxic Assay | GI50=3.0 × 10-7 μg/mL | 14640532 | |||
| HT1080 | Growth Inhibition Assay | 72 h | DMSO | IC50=0.059 μM | 14640513 | |
| Neuro2A | Function Assay | 3 ug/mL | 24 h | Neuritogenic activity assessed as morphological changes | 14575440 | |
| RXF944L | Growth Inhibition Assay | 72 h | DMSO | IC50=0.06 μM | 12852768 | |
| LXF629L | Growth Inhibition Assay | 72 h | DMSO | IC50=0.07 μM | 12852768 | |
| LXF529L | Growth Inhibition Assay | 72 h | DMSO | IC50=0.03 μM | 12852768 | |
| 401NL | Growth Inhibition Assay | 72 h | DMSO | IC50=0.01 μM | 12852768 | |
| L2987 | Cytotoxic Assay | IC50=0.3 μM | 12798317 | |||
| P388 | Growth Inhibition Assay | 72 h | IC50=0.015 μM | 12620081 | ||
| Jurkat | Growth Inhibition Assay | 72 h | IC50=0.0096 μM | 12620081 | ||
| 8226/S | Cytotoxic Assay | 72 h | DMSO | Cytotoxity against 8226/S | 12570378 | |
| 8226/DOX1V | Cytotoxic Assay | 72 h | DMSO | Cytotoxity against 8226/DOX1V | 12570378 | |
| LXFL529 | Growth Inhibition Assay | 36 h | IC50=0.04 μM | 12459020 | ||
| L1210 | Cytotoxic Assay | 48 h | DMSO | IC50=0.025 μM | 12443763 | |
| HET-SR-2SC-LNM | Growth Inhibition Assay | 72 h | deionized water | IC50=0.052 μM | 12431060 | |
| 2SC/20 | Growth Inhibition Assay | 72 h | deionized water | IC50=0.62 μM | 12431060 | |
| Wil-NS | Growth Inhibition Assay | 96 h | DMSO | IC50=0.02 μM | 12431049 | |
| Raji | Growth Inhibition Assay | 96 h | DMSO | IC50=0.03 μM | 12431049 | |
| Hep-2 | Growth Inhibition Assay | 96 h | DMSO | IC50=0.04 μM | 12431049 | |
| SK-MES-1 | Cytotoxic Assay | 6 d | DMSO | IC50=0.03 μM | 12431048 | |
| SKMEL-28 | Cytotoxic Assay | 6 d | DMSO | IC50=0.06 μM | 12431048 | |
| CRL7065 | Cytotoxic Assay | 6 d | DMSO | IC50=0.5 μM | 12431048 | |
| UMUC3 | Cytotoxic Assay | IC50=0.0092 μM | 12392727 | |||
| U251 | Cytotoxic Assay | IC50=0.09 μM | 12039588 | |||
| H69P | Growth Inhibition Assay | 4 d | IC50=0.027 μM | 11806725 | ||
| H69/LX4 | Growth Inhibition Assay | 4 d | Inhibitory activity against drug resistant H69/LX4 cell overexpressing P-glycoprotein with IC50 of 0.137 μM | 11806725 | ||
| H69P | Cytotoxic Assay | 5-6 d | IC50=0.0273 μM | 11806724 | ||
| COR-L23 | Cytotoxic Assay | 5-6 d | IC50=0.0201 μM | 11806724 | ||
| HCT116 | Growth Inhibition Assay | GI50=0.023 μM | 11755363 | |||
| SKVLB1 | Cytotoxic Assay | 72 h | DMSO | Cytotoxicity against human multidrug-resistant SKVLB1 cell with IC50 of 2.2 μM | 11754602 | |
| UACC62 | Cytotoxic Assay | 3-5 m | DMSO | GI50=0.094 μM | 11678649 | |
| U87 | Cytotoxic Assay | 10 μM | DMSO | Cytotoxicity against U87 resistant cell with IC50 of 0.14 μM | 11606141 | |
| U87 | Cytotoxic Assay | 10 μM | DMSO | Cytotoxicity against U87 sensitive cell with IC50 of 0.06 μM | 11606141 | |
| U373 | Cytotoxic Assay | 10 μM | DMSO | Cytotoxicity against U373 sensitive cell with IC50 of 0.01 μM | 11606141 | |
| T24 | Cytotoxic Assay | 10 μM | DMSO | Cytotoxicity against T24 sensitive cell with IC50 of 0.02 μM | 11606141 | |
| LoVo | Cytotoxic Assay | 10 μM | DMSO | Cytotoxicity against LoVo sensitive cell with IC50 of 0.008 μM | 11606141 | |
| J82 | Cytotoxic Assay | 10 μM | DMSO | Cytotoxicity against J82 sensitive cell with IC50 of 0.03 μM | 11606141 | |
| CNS | Growth Inhibition Assay | 48 h | GI50=0.064 μM | 11473418 | ||
| RENCA | Growth Inhibition Assay | 48 h | IC50<0.01 μM | 11454467 | ||
| CH1 | Cytotoxic Assay | 96 h | DMSO | IC50=0.0063 μM | 11123989 | |
| UA375 | Cytotoxic Assay | 24 h | DMSO | IC50=0.112 μM | 10956214 | |
| OVCAR-3 | Cytotoxic Assay | 24 h | DMSO | IC50=0.035 μM | 10956214 | |
| D40 | Cytotoxic Assay | 24 h | DMSO | IC50=1.172 μM | 10956214 | |
| L1210 | Cytotoxic Assay | IC50=0.025 μM | 10890167 | |||
| ZR-75-1 | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against ZR-75-1 cell (ER+,pgr+,mutant p53) with IC50 of 0.009 μM | 10780913 |
| T47D | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against T47D cell (ER+,mutant p53) with IC50 of 0.007 μM | 10780913 |
| SKBR-3 | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against SKBR-3 cell (ER-amplified erB2,mutant p53) with IC50 of 0.02 μM | 10780913 |
| NCI-H647 | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against NCI-H647 cell (mutant p53) with IC50 of 0.001 μM | 10780913 |
| NCI-H358 | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against NCI-H358 cell (mutant p53) with IC50 of 0.13 μM | 10780913 |
| NCI-H322 | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against NCI-H322 cell (mutant p53) with IC50 of 0.03 μM | 10780913 |
| NCI-H226 | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against NCI-H226 cell (mutant p53) with IC50 of 0.008 μM | 10780913 |
| MDA-468 | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against MDA-468 cell (ER-, amplified EGFR, mutant p53) with IC50 of 0.005 μM | 10780913 |
| MDA-231 | Cytotoxic Assay | 100 μM | 48 h | Saline | Cytotoxicity against MDA-231 cell (ER-,EGFR+,mutant p53) with IC50 of 0.006 μM | 10780913 |
| H460pv8 | Cytotoxic Assay | 100 μM | 48 h | Saline | IC50=0.004 μM | 10780913 |
| H460pv8/eto | Cytotoxic Assay | 100 μM | 48 h | Saline | IC50=0.02 μM | 10780913 |
| U937 | Function Assay | 24 h | DMSO | Inhibits incorporation of [3H]thymidine with IC50 of 0.1 μM | 10780911 | |
| T24 | Growth Inhibition Assay | IC50=0.64 μM | 10698436 | |||
| PC14 | Growth Inhibition Assay | IC50=1.9 μM | 10698436 | |||
| MKN-1 | Growth Inhibition Assay | IC50=0.64 μM | 10698436 | |||
| HMV-1 | Growth Inhibition Assay | IC50=0.28 μM | 10698436 | |||
| P388 | Cytotoxic Assay | 72 h | GI50=0.012 μM | 10691710 | ||
| 3Y1 | Cytotoxic Assay | 72 h | GI50=0.0038 μM | 10691710 | ||
| PACA-2 | Cytotoxic Assay | 6 d | ED50=0.0063 μM | 10498214 | ||
| K562R | Cytotoxic Assay | 72 h | IC50=0.0156 μM | 10479282 | ||
| DU145 | Cytotoxic Assay | 72 h | IC50=0.0528 μM | 10479282 | ||
| MEL-AC | Cytotoxic Assay | 100 μM | IC50=1.2 μM | 10476861 | ||
| HTB-54 | Cytotoxic Assay | 100 μM | IC50=1.1 μM | 10476861 | ||
| KB | Growth Inhibition Assay | 4 d | DMSO | Antiproliferative activity against drug-resistant KBV20C with IC50 of 0.4 μM | 10411476 | |
| KB | Growth Inhibition Assay | 4 d | DMSO | Antiproliferative activity against drug-resistant KBMDR with IC50 of 0.5 μM | 10411476 | |
| KB | Growth Inhibition Assay | 4 d | DMSO | Antiproliferative activity against drug-resistant KBCampwith IC50 of 0.06 μM | 10411476 | |
| KB | Growth Inhibition Assay | 4 d | DMSO | Antiproliferative activity against drug-resistant KB7D with IC50 of 0.65 μM | 10411476 | |
| CHO-K1 | Growth Inhibition Assay | 4 d | DMSO | IC50=0.4 μM | 10411476 | |
| CCRF-SB | Growth Inhibition Assay | 4 d | DMSO | IC50=0.01 μM | 10411476 | |
| MDA-MB-361 | Cytotoxic Assay | 1 h | DMSO | Cytotoxicity against MDA MB 361 expressing carboxypeptidase stCPG2 with IC50 of 0.018 μM | 10395490 | |
| MDA-MB-361 | Cytotoxic Assay | 1 h | DMSO | Cytotoxicity against MDA-MB-361 expressing LacZ with IC50 of 0.012 μM | 10395490 | |
| SF-295 | Cytotoxic Assay | 72 h | IC50=0.035 μM | 9873661 | ||
| HOP62 | Cytotoxic Assay | 72 h | IC50=0.004 μM | 9873661 | ||
| PC14 | Cytotoxic Assay | 4 d | DMSO | IC50=0.29 μM | 9822542 | |
| Panc02 | Growth Inhibition Assay | 10 μM | 6 d | IC50=0.065 μM | 9526570 | |
| CHO | Growth Inhibition Assay | 10 μM | 6 d | IC50=0.06 μM | 9526570 | |
| CA755 | Growth Inhibition Assay | 10 μM | 6 d | IC50=0.014 μM | 9526570 | |
| MCF7/VP16 | Cytotoxic Assay | 50 μg/mL | 72 h | IC50=14.2 μM | 9022792 | |
| SKVLB | Cytotoxic Assay | 72 h | IC50=6.54 μM | 9003520 | ||
| C6 | Cytotoxic Assay | 2.5 mg/mL | 5 h | DMSO | Cytotoxicity assessed as cell release | 8988604 |
| C6 | Function Assay | 2.5 mg/mL | 4 h | DMSO | Inhibition of tubulin polymerization | 8988604 |
| C6 | Cytotoxic Assay | 2.5 mg/mL | 72 h | DMSO | Cytotoxicity against rat C6 cells at 50 ug/mL to 2.5 mg/mL | 8988604 |
| MCF | Function Assay | Reversal of P-gp-mediated multidrug resistance assessed as enhancement in cytotoxicity of adriamycin | 8984151 | |||
| WiDr | Cytotoxic Assay | Activity against sensitive WiDr cell with IC50 of 0.053 μM | 8960558 | |||
| MXF7 | Cytotoxic Assay | Antitumor activity against doxorubicin-resistant MXF7 with IC50 of 1.172 μM | 8960558 | |||
| MXF7 | Cytotoxic Assay | Antitumor activity against MXF7 with IC50 of 0.028 μM | 8960558 | |||
| MXF7 | Cytotoxic Assay | Antitumor activity against sensitive MXF7 with IC50 of 0.028 μM | 8960558 | |||
| A2780-DX5 | Cytotoxic Assay | Cytotoxicity against doxorubicin-resistant A2780-DX5 with IC50 of 0.357 μM | 8831755 | |||
| A2780-CP3 | Cytotoxic Assay | Cytotoxicity against A2780-CP3 with IC50 of 0.056 μM | 8831755 | |||
| A2780-C25 | Cytotoxic Assay | Cytotoxicity against A2780-C25 with IC50 of 0.063 μM | 8831755 | |||
| AUC375 | Growth Inhibition Assay | IC50=0.112 μM | 8648600 | |||
| SKVLB | Cytotoxic Assay | IC50=5.6 μM | 8576914 | |||
| EAC | Cytotoxic Assay | 72 h | IC50=0.35 μM | 8350087 | ||
| C38 | Cytotoxic Assay | IC50=0.01 μM | 8057291 | |||
| LOX | Cytotoxic Assay | IC50=0.042 μM | 7853331 | |||
| H2981 | Cytotoxic Assay | IC50=0.5 μM | 7731023 | |||
| EMT6 | Growth Inhibition Assay | 0.5 μM | 1 h | Inhibition of proliferation by measuring for surviving fractions with ED50 of 0.0001 μM | 7452674 | |
| HT-29 | Growth Inhibition Assay | 0.01 μg | 48 h | Antiproliferative activity | 2778449 | |
| KBM-3 | Growth Inhibition Assay | IC50=0.026 μM | 1995877 | |||
| MLM | Cytotoxic Assay | ED50=0.13 μM | 1875350 | |||
| SKMEL-5 | Growth Inhibition Assay | ED50=3.2 μM | 1613753 | |||
| T-MT4 | Growth Inhibition Assay | ID50=0.01 μM | 1548681 | |||
| T-H9 | Growth Inhibition Assay | ID50=0.01 μM | 1548681 | |||
| T-C8166 | Growth Inhibition Assay | ID50=0.01 μM | 1548681 | |||
| H9 | Growth Inhibition Assay | Inhibition of H9 cells chronically infected with the HIV-1 (H9/IIIB) with ID50 of 0.01 μM | 1548681 | |||
| N417 | Growth Inhibition Assay | IC50=0.23 μM | 1479585 | |||
| H69 | Growth Inhibition Assay | IC50=0.87 μM | 1479585 | |||
| MCF7/ADR | Growth Inhibition Assay | IC50=3.1 μM | 1447730 | |||
| 8226/ADR | Growth Inhibition Assay | IC50=0.56 μM | 1447730 | |||
| 8226 | Growth Inhibition Assay | IC50=0.033 μM | 1447730 | |||
| CHO | Growth Inhibition Assay | IC50=0.06 μM | 1354750 | |||
| Yoshida sarcoma | Function Assay | Inhibition of [3H]TdR incorporation with IC50 of 0.02 μM | 1322986 | |||
| L1210 | Function Assay | Inhibition of RNA synthesis with ED50 of 0.58 μM | 490536 | |||
| A431 | Cytotoxic Assay | IC50=0.00135 μM | 24890652 | |||
| HT-29 | Function Assay | 25 μM | 24 h | Inhibition of MRP3-mediated drug resistance in doxorubicin-resistant human HT-29 cells assessed as increase in drug accumulation | 24900337 | |
| HT-29 | Function Assay | 5 μM | 24 h | Inhibition of MRP3 in doxorubicin-resistant human HT-29 cells assessed as nitration of tyrosine residues | 24900337 | |
| HT-29 | Function Assay | 5 μM | 1 h | Inhibition of MRP3-mediated drug resistance in doxorubicin-resistant human HT-29 cells assessed as increase in drug accumulation | 24900337 | |
| HT-29 | Function Assay | 5 μM | 1 h | Induction of nitrite production in doxorubicin-resistant human HT-29 cells | 24900337 | |
| NAR | Function Assay | 5 μM | 2 h | Drug uptake in doxorubicin-resistant human NAR cell plasma membrane | 24900344 | |
| NAR | Cytotoxic Assay | 10 μM | 24 h | Cytotoxicity assessed as induction of cell death | 24900344 | |
| NAR | Cytotoxic Assay | 100 μM | 24 h | Cytotoxicity against doxorubicin-resistant human NAR cells assessed as cell viability | 24900344 | |
| DA-3 | Cytotoxic Assay | 60 μM | 24 h | IC50=4 μM | 24900668 | |
| DA-3 | Function Assay | 10 μM | 10 h | Cellular uptake in mouse DA-3 cell mitochondria | 24900668 | |
| DA-3 | Function Assay | 10 μM | 10 h | Cellular uptake in mouse DA-3 cell lysosome | 24900668 | |
| DA-3 | Function Assay | 10 μM | 10 h | Cellular uptake in mouse DA-3 cell nucleus | 24900668 | |
| YOYO1 | Function Assay | Displacement of YOYO1 from phage lambda DNA with IC50 of 0.6 μM | 24900668 | |||
| KCL22 | Growth Inhibition Assay | 48 h | IC50=1.8 μM | 24941129 | ||
| Saos2 | Growth Inhibition Assay | 40 μM | 24 h | DMSO | IC50=0.33 μM | 24941130 |
| IMR32 | Cytotoxic Assay | 250 μM | 48 h | DMSO | IC50=0.0051 μM | 24996140 |
| NTERA-S-cl-D1 | Growth Inhibition Assay | IC50=1.37 nM | SANGER | |||
| EW-16 | Growth Inhibition Assay | IC50=1.91 nM | SANGER | |||
| HUTU-80 | Growth Inhibition Assay | IC50=2.12 nM | SANGER | |||
| KS-1 | Growth Inhibition Assay | IC50=3.44 nM | SANGER | |||
| HT-144 | Growth Inhibition Assay | IC50=3.51 nM | SANGER | |||
| MFH-ino | Growth Inhibition Assay | IC50=3.99 nM | SANGER | |||
| LC-2 | Growth Inhibition Assay | IC50=5.07 nM | SANGER | |||
| SW982 | Growth Inhibition Assay | IC50=6.05 nM | SANGER | |||
| ES4 | Growth Inhibition Assay | IC50=6.11 nM | SANGER | |||
| KGN | Growth Inhibition Assay | IC50=6.34 nM | SANGER | |||
| RH-1 | Growth Inhibition Assay | IC50=6.73 nM | SANGER | |||
| IGROV-1 | Growth Inhibition Assay | IC50=7.2 nM | SANGER | |||
| KYSE-270 | Growth Inhibition Assay | IC50=7.21 nM | SANGER | |||
| TE-8 | Growth Inhibition Assay | IC50=7.5 nM | SANGER | |||
| Daoy | Growth Inhibition Assay | IC50=8.07 nM | SANGER | |||
| REH | Growth Inhibition Assay | IC50=8.11 nM | SANGER | |||
| 786-0 | Growth Inhibition Assay | IC50=8.47 nM | SANGER | |||
| A375 | Growth Inhibition Assay | IC50=9.17 nM | SANGER | |||
| EW-13 | Growth Inhibition Assay | IC50=9.63 nM | SANGER | |||
| MKN1 | Growth Inhibition Assay | IC50=9.86 nM | SANGER | |||
| MV-4-11 | Growth Inhibition Assay | IC50=10.03 nM | SANGER | |||
| ESS-1 | Growth Inhibition Assay | IC50=11.09 nM | SANGER | |||
| PSN1 | Growth Inhibition Assay | IC50=11.22 nM | SANGER | |||
| MCF7 | Growth Inhibition Assay | IC50=11.65 nM | SANGER | |||
| A427 | Growth Inhibition Assay | IC50=11.81 nM | SANGER | |||
| NCI-H1651 | Growth Inhibition Assay | IC50=11.83 nM | SANGER | |||
| LCLC-97TM1 | Growth Inhibition Assay | IC50=11.83 nM | SANGER | |||
| DU-4475 | Growth Inhibition Assay | IC50=12.1 nM | SANGER | |||
| SK-LU-1 | Growth Inhibition Assay | IC50=12.54 nM | SANGER | |||
| NCI-H460 | Growth Inhibition Assay | IC50=12.7 nM | SANGER | |||
| A204 | Growth Inhibition Assay | IC50=12.88 nM | SANGER | |||
| AGS | Growth Inhibition Assay | IC50=13.27 nM | SANGER | |||
| NCI-H2228 | Growth Inhibition Assay | IC50=13.48 nM | SANGER | |||
| HGC-27 | Growth Inhibition Assay | IC50=13.56 nM | SANGER | |||
| RPMI-2650 | Growth Inhibition Assay | IC50=13.69 nM | SANGER | |||
| ES1 | Growth Inhibition Assay | IC50=13.72 nM | SANGER | |||
| MEL-JUSO | Growth Inhibition Assay | IC50=14.5 nM | SANGER | |||
| HT-1080 | Growth Inhibition Assay | IC50=14.82 nM | SANGER | |||
| OCUB-M | Growth Inhibition Assay | IC50=15.15 nM | SANGER | |||
| 23132-87 | Growth Inhibition Assay | IC50=15.42 nM | SANGER | |||
| KYSE-510 | Growth Inhibition Assay | IC50=15.48 nM | SANGER | |||
| ST486 | Growth Inhibition Assay | IC50=15.53 nM | SANGER | |||
| 639-V | Growth Inhibition Assay | IC50=15.91 nM | SANGER | |||
| COLO-679 | Growth Inhibition Assay | IC50=15.97 nM | SANGER | |||
| CTV-1 | Growth Inhibition Assay | IC50=16.07 nM | SANGER | |||
| BFTC-905 | Growth Inhibition Assay | IC50=16.18 nM | SANGER | |||
| SW954 | Growth Inhibition Assay | IC50=16.93 nM | SANGER | |||
| CAL-51 | Growth Inhibition Assay | IC50=17.32 nM | SANGER | |||
| SW1710 | Growth Inhibition Assay | IC50=17.4 nM | SANGER | |||
| HCC2998 | Growth Inhibition Assay | IC50=17.44 nM | SANGER | |||
| A2058 | Growth Inhibition Assay | IC50=17.65 nM | SANGER | |||
| HCE-4 | Growth Inhibition Assay | IC50=18.07 nM | SANGER | |||
| MEL-HO | Growth Inhibition Assay | IC50=18.3 nM | SANGER | |||
| SNG-M | Growth Inhibition Assay | IC50=18.32 nM | SANGER | |||
| LS-123 | Growth Inhibition Assay | IC50=18.46 nM | SANGER | |||
| NALM-6 | Growth Inhibition Assay | IC50=18.63 nM | SANGER | |||
| NCI-H810 | Growth Inhibition Assay | IC50=18.76 nM | SANGER | |||
| YKG-1 | Growth Inhibition Assay | IC50=18.77 nM | SANGER | |||
| 647-V | Growth Inhibition Assay | IC50=18.81 nM | SANGER | |||
| ONS-76 | Growth Inhibition Assay | IC50=18.91 nM | SANGER | |||
| 697 | Growth Inhibition Assay | IC50=19.09 nM | SANGER | |||
| RS4-11 | Growth Inhibition Assay | IC50=19.14 nM | SANGER | |||
| 8505C | Growth Inhibition Assay | IC50=19.56 nM | SANGER | |||
| SK-UT-1 | Growth Inhibition Assay | IC50=19.96 nM | SANGER | |||
| DOHH-2 | Growth Inhibition Assay | IC50=19.99 nM | SANGER | |||
| NCCIT | Growth Inhibition Assay | IC50=20.13 nM | SANGER | |||
| LCLC-103H | Growth Inhibition Assay | IC50=20.54 nM | SANGER | |||
| CAL-12T | Growth Inhibition Assay | IC50=20.65 nM | SANGER | |||
| QIMR-WIL | Growth Inhibition Assay | IC50=20.72 nM | SANGER | |||
| SBC-5 | Growth Inhibition Assay | IC50=20.74 nM | SANGER | |||
| 769-P | Growth Inhibition Assay | IC50=20.76 nM | SANGER | |||
| A431 | Growth Inhibition Assay | IC50=20.87 nM | SANGER | |||
| KE-37 | Growth Inhibition Assay | IC50=21.05 nM | SANGER | |||
| ES8 | Growth Inhibition Assay | IC50=21.07 nM | SANGER | |||
| 22RV1 | Growth Inhibition Assay | IC50=21.24 nM | SANGER | |||
| LOUCY | Growth Inhibition Assay | IC50=21.32 nM | SANGER | |||
| J82 | Growth Inhibition Assay | IC50=21.34 nM | SANGER | |||
| MHH-ES-1 | Growth Inhibition Assay | IC50=21.58 nM | SANGER | |||
| MG-63 | Growth Inhibition Assay | IC50=22.08 nM | SANGER | |||
| 8-MG-BA | Growth Inhibition Assay | IC50=22.12 nM | SANGER | |||
| BPH-1 | Growth Inhibition Assay | IC50=22.12 nM | SANGER | |||
| RKO | Growth Inhibition Assay | IC50=22.28 nM | SANGER | |||
| HMV-II | Growth Inhibition Assay | IC50=22.6 nM | SANGER | |||
| NCI-H727 | Growth Inhibition Assay | IC50=22.79 nM | SANGER | |||
| MOLT-4 | Growth Inhibition Assay | IC50=22.86 nM | SANGER | |||
| NCI-H2342 | Growth Inhibition Assay | IC50=22.91 nM | SANGER | |||
| MZ1-PC | Growth Inhibition Assay | IC50=23.81 nM | SANGER | |||
| TE-15 | Growth Inhibition Assay | IC50=24.14 nM | SANGER | |||
| SR | Growth Inhibition Assay | IC50=24.41 nM | SANGER | |||
| CCRF-CEM | Growth Inhibition Assay | IC50=24.52 nM | SANGER | |||
| SIG-M5 | Growth Inhibition Assay | IC50=25.69 nM | SANGER | |||
| SK-PN-DW | Growth Inhibition Assay | IC50=25.72 nM | SANGER | |||
| SK-HEP-1 | Growth Inhibition Assay | IC50=25.86 nM | SANGER | |||
| SW620 | Growth Inhibition Assay | IC50=26.63 nM | SANGER | |||
| HSC-2 | Growth Inhibition Assay | IC50=26.78 nM | SANGER | |||
| CAL-148 | Growth Inhibition Assay | IC50=26.9 nM | SANGER | |||
| COLO-205 | Growth Inhibition Assay | IC50=26.99 nM | SANGER | |||
| EoL-1-cell | Growth Inhibition Assay | IC50=27.78 nM | SANGER | |||
| KYSE-150 | Growth Inhibition Assay | IC50=27.78 nM | SANGER | |||
| G-361 | Growth Inhibition Assay | IC50=28.88 nM | SANGER | |||
| PANC-03-27 | Growth Inhibition Assay | IC50=28.16 nM | SANGER | |||
| NCI-H2030 | Growth Inhibition Assay | IC50=28.26 nM | SANGER | |||
| NCI-H441 | Growth Inhibition Assay | IC50=28.42 nM | SANGER | |||
| A388 | Growth Inhibition Assay | IC50=28.46 nM | SANGER | |||
| BHY | Growth Inhibition Assay | IC50=28.88 nM | SANGER | |||
| KALS-1 | Growth Inhibition Assay | IC50=29.33 nM | SANGER | |||
| NKM-1 | Growth Inhibition Assay | IC50=29.47 nM | SANGER | |||
| BB30-HNC | Growth Inhibition Assay | IC50=29.85 nM | SANGER | |||
| G-401 | Growth Inhibition Assay | IC50=30.2 nM | SANGER | |||
| EW-7 | Growth Inhibition Assay | IC50=30.63 nM | SANGER | |||
| CAN | Growth Inhibition Assay | IC50=31.12 nM | SANGER | |||
| M059J | Growth Inhibition Assay | IC50=31.37 nM | SANGER | |||
| SK-MES-1 | Growth Inhibition Assay | IC50=31.5 nM | SANGER | |||
| 5637 | Growth Inhibition Assay | IC50=31.87 nM | SANGER | |||
| MKN28 | Growth Inhibition Assay | IC50=31.91 nM | SANGER | |||
| COR-L23 | Growth Inhibition Assay | IC50=31.96 nM | SANGER | |||
| CAL-27 | Growth Inhibition Assay | IC50=32.57 nM | SANGER | |||
| CAL-62 | Growth Inhibition Assay | IC50=32.79 nM | SANGER | |||
| C-33-A | Growth Inhibition Assay | IC50=32.89 nM | SANGER | |||
| RT-112 | Growth Inhibition Assay | IC50=32.92 nM | SANGER | |||
| KU812 | Growth Inhibition Assay | IC50=33.24 nM | SANGER | |||
| C8166 | Growth Inhibition Assay | IC50=33.31 nM | SANGER | |||
| VA-ES-BJ | Growth Inhibition Assay | IC50=33.36 nM | SANGER | |||
| NEC8 | Growth Inhibition Assay | IC50=33.61 nM | SANGER | |||
| EB2 | Growth Inhibition Assay | IC50=33.73 nM | SANGER | |||
| COLO-680N | Growth Inhibition Assay | IC50=33.87 nM | SANGER | |||
| IGR-1 | Growth Inhibition Assay | IC50=33.83 nM | SANGER | |||
| MZ2-MEL | Growth Inhibition Assay | IC50=33.92 nM | SANGER | |||
| MIA-PaCa-2 | Growth Inhibition Assay | IC50=34.24 nM | SANGER | |||
| IMR-5 | Growth Inhibition Assay | IC50=34.68 nM | SANGER | |||
| CHP-212 | Growth Inhibition Assay | IC50=34.96 nM | SANGER | |||
| CCF-STTG1 | Growth Inhibition Assay | IC50=35.5 nM | SANGER | |||
| SK-MEL-30 | Growth Inhibition Assay | IC50=35.61 nM | SANGER | |||
| HLE | Growth Inhibition Assay | IC50=35.8 nM | SANGER | |||
| HOP-62 | Growth Inhibition Assay | IC50=35.88 nM | SANGER | |||
| LB1047-RCC | Growth Inhibition Assay | IC50=35.97 nM | SANGER | |||
| DoTc2-4510 | Growth Inhibition Assay | IC50=36.25 nM | SANGER | |||
| HT-29 | Growth Inhibition Assay | IC50=36.57 nM | SANGER | |||
| HC-1 | Growth Inhibition Assay | IC50=37.32 nM | SANGER | |||
| TE-5 | Growth Inhibition Assay | IC50=37.48 nM | SANGER | |||
| NCI-H1299 | Growth Inhibition Assay | IC50=37.59 nM | SANGER | |||
| CHL-1 | Growth Inhibition Assay | IC50=37.73 nM | SANGER | |||
| NCI-H2122 | Growth Inhibition Assay | IC50=37.9 nM | SANGER | |||
| DEL | Growth Inhibition Assay | IC50=38.44 nM | SANGER | |||
| ES5 | Growth Inhibition Assay | IC50=39.22 nM | SANGER | |||
| CESS | Growth Inhibition Assay | IC50=39.36 nM | SANGER | |||
| NCI-H719 | Growth Inhibition Assay | IC50=39.65 nM | SANGER | |||
| A3-KAW | Growth Inhibition Assay | IC50=40.14 nM | SANGER | |||
| KP-4 | Growth Inhibition Assay | IC50=40.77 nM | SANGER | |||
| NCI-H358 | Growth Inhibition Assay | IC50=41.08 nM | SANGER | |||
| HCC38 | Growth Inhibition Assay | IC50=42.5 nM | SANGER | |||
| MRK-nu-1 | Growth Inhibition Assay | IC50=43.66 nM | SANGER | |||
| NCI-H292 | Growth Inhibition Assay | IC50=43.76 nM | SANGER | |||
| PA-1 | Growth Inhibition Assay | IC50=44.48 nM | SANGER | |||
| CAL-85-1 | Growth Inhibition Assay | IC50=44.52 nM | SANGER | |||
| KYSE-450 | Growth Inhibition Assay | IC50=44.71 nM | SANGER | |||
| IST-MEL1 | Growth Inhibition Assay | IC50=44.84 nM | SANGER | |||
| Ca-Ski | Growth Inhibition Assay | IC50=44.84 nM | SANGER | |||
| OCI-AML2 | Growth Inhibition Assay | IC50=45.05 nM | SANGER | |||
| NUGC-3 | Growth Inhibition Assay | IC50=45.2 nM | SANGER | |||
| HOS | Growth Inhibition Assay | IC50=45.29 nM | SANGER | |||
| NB1 | Growth Inhibition Assay | IC50=45.99 nM | SANGER | |||
| A253 | Growth Inhibition Assay | IC50=46.12 nM | SANGER | |||
| NCI-H209 | Growth Inhibition Assay | IC50=48.73 nM | SANGER | |||
| MC-CAR | Growth Inhibition Assay | IC50=48.74 nM | SANGER | |||
| NCI-H661 | Growth Inhibition Assay | IC50=49.03 nM | SANGER | |||
| SF295 | Growth Inhibition Assay | IC50=49.08 nM | SANGER | |||
| GP5d | Growth Inhibition Assay | IC50=49.12 nM | SANGER | |||
| P12-ICHIKAWA | Growth Inhibition Assay | IC50=49.27 nM | SANGER | |||
| ACHN | Growth Inhibition Assay | IC50=49.34 nM | SANGER | |||
| NCI-H2087 | Growth Inhibition Assay | IC50=49.42 nM | SANGER | |||
| SW48 | Growth Inhibition Assay | IC50=49.72 nM | SANGER | |||
| NCI-H526 | Growth Inhibition Assay | IC50=49.96 nM | SANGER | |||
| Ca9-22 | Growth Inhibition Assay | IC50=50.07 nM | SANGER | |||
| SK-OV-3 | Growth Inhibition Assay | IC50=50.12 nM | SANGER | |||
| KYSE-140 | Growth Inhibition Assay | IC50=50.42 nM | SANGER | |||
| BE-13 | Growth Inhibition Assay | IC50=51.02 nM | SANGER | |||
| ES7 | Growth Inhibition Assay | IC50=51.4 nM | SANGER | |||
| IM-9 | Growth Inhibition Assay | IC50=51.43 nM | SANGER | |||
| A101D | Growth Inhibition Assay | IC50=51.48 nM | SANGER | |||
| CAPAN-1 | Growth Inhibition Assay | IC50=51.76 nM | SANGER | |||
| NCI-H2009 | Growth Inhibition Assay | IC50=51.76 nM | SANGER | |||
| NCI-H522 | Growth Inhibition Assay | IC50=51.93 nM | SANGER | |||
| HuP-T4 | Growth Inhibition Assay | IC50=52.22 nM | SANGER | |||
| BCPAP | Growth Inhibition Assay | IC50=52.5 nM | SANGER | |||
| NCI-H1734 | Growth Inhibition Assay | IC50=53 nM | SANGER | |||
| SK-LMS-1 | Growth Inhibition Assay | IC50=53.22 nM | SANGER | |||
| CGTH-W-1 | Growth Inhibition Assay | IC50=53.46 nM | SANGER | |||
| RPMI-8402 | Growth Inhibition Assay | IC50=53.86 nM | SANGER | |||
| Calu-3 | Growth Inhibition Assay | IC50=55.98 nM | SANGER | |||
| COR-L279 | Growth Inhibition Assay | IC50=56.95 nM | SANGER | |||
| T84 | Growth Inhibition Assay | IC50=57.06 nM | SANGER | |||
| P30-OHK | Growth Inhibition Assay | IC50=57.57 nM | SANGER | |||
| CHP-126 | Growth Inhibition Assay | IC50=59.24 nM | SANGER | |||
| KYSE-180 | Growth Inhibition Assay | IC50=59.75 nM | SANGER | |||
| CAMG | Growth Inhibition Assay | IC50=59.96 nM | SANGER | |||
| EW-1 | Growth Inhibition Assay | IC50=61.35 nM | SANGER | |||
| OVCAR-8 | Growth Inhibition Assay | IC50=61.92 nM | SANGER | |||
| HL-60 | Growth Inhibition Assay | IC50=62.56 nM | SANGER | |||
| 8305C | Growth Inhibition Assay | IC50=63.12 nM | SANGER | |||
| IA-LM | Growth Inhibition Assay | IC50=63.54 nM | SANGER | |||
| HCC2157 | Growth Inhibition Assay | IC50=63.95 nM | SANGER | |||
| CTB-1 | Growth Inhibition Assay | IC50=64019 nM | SANGER | |||
| NCI-H1437 | Growth Inhibition Assay | IC50=64.64 nM | SANGER | |||
| U251 | Growth Inhibition Assay | IC50=64.89 nM | SANGER | |||
| ALL-PO | Growth Inhibition Assay | IC50=65.03 nM | SANGER | |||
| NCI-SNU-1 | Growth Inhibition Assay | IC50=65.86 nM | SANGER | |||
| RPMI-6666 | Growth Inhibition Assay | IC50=65.99 nM | SANGER | |||
| DBTRG-05MG | Growth Inhibition Assay | IC50=67.11 nM | SANGER | |||
| PF-382 | Growth Inhibition Assay | IC50=67.17 nM | SANGER | |||
| GT3TKB | Growth Inhibition Assay | IC50=67.19 nM | SANGER | |||
| SCC-3 | Growth Inhibition Assay | IC50=67.28 nM | SANGER | |||
| LU-134-A | Growth Inhibition Assay | IC50=67.68 nM | SANGER | |||
| CAL-33 | Growth Inhibition Assay | IC50=67.87 nM | SANGER | |||
| MC-IXC | Growth Inhibition Assay | IC50=67.9 nM | SANGER | |||
| CPC-N | Growth Inhibition Assay | IC50=68.4 nM | SANGER | |||
| A2780 | Growth Inhibition Assay | IC50=68.79 nM | SANGER | |||
| Daudi | Growth Inhibition Assay | IC50=68.96 nM | SANGER | |||
| GI-1 | Growth Inhibition Assay | IC50=69.65 nM | SANGER | |||
| SW962 | Growth Inhibition Assay | IC50=69.95 nM | SANGER | |||
| MFE-296 | Growth Inhibition Assay | IC50=70.49 nM | SANGER | |||
| H4 | Growth Inhibition Assay | IC50=71.56 nM | SANGER | |||
| AN3-CA | Growth Inhibition Assay | IC50=72.32 nM | SANGER | |||
| HCC1599 | Growth Inhibition Assay | IC50=72.54 nM | SANGER | |||
| HuCCT1 | Growth Inhibition Assay | IC50=72.93 nM | SANGER | |||
| Calu-1 | Growth Inhibition Assay | IC50=73.6 nM | SANGER | |||
| DU-145 | Growth Inhibition Assay | IC50=73.73 nM | SANGER | |||
| IST-SL2 | Growth Inhibition Assay | IC50=73.81 nM | SANGER | |||
| HSC-3 | Growth Inhibition Assay | IC50=74.53 nM | SANGER | |||
| HCC1806 | Growth Inhibition Assay | IC50=74.96 nM | SANGER | |||
| VM-CUB-1 | Growth Inhibition Assay | IC50=75.36 nM | SANGER | |||
| HSC-4 | Growth Inhibition Assay | IC50=75.76 nM | SANGER | |||
| NH-12 | Growth Inhibition Assay | IC50=76 nM | SANGER | |||
| MDA-MB-468 | Growth Inhibition Assay | IC50=76.18 nM | SANGER | |||
| TUR | Growth Inhibition Assay | IC50=76.32 nM | SANGER | |||
| TE-1 | Growth Inhibition Assay | IC50=76.35 nM | SANGER | |||
| CMK | Growth Inhibition Assay | IC50=77.42 nM | SANGER | |||
| LB996-RCC | Growth Inhibition Assay | IC50=78.45 nM | SANGER | |||
| NCI-H1650 | Growth Inhibition Assay | IC50=78.62 nM | SANGER | |||
| DMS-273 | Growth Inhibition Assay | IC50=78.9 nM | SANGER | |||
| NOS-1 | Growth Inhibition Assay | IC50=79.14 nM | SANGER | |||
| NB69 | Growth Inhibition Assay | IC50=79.2 nM | SANGER | |||
| SUP-T1 | Growth Inhibition Assay | IC50=79.72 nM | SANGER | |||
| A172 | Growth Inhibition Assay | IC50=80.55 nM | SANGER | |||
| TE-12 | Growth Inhibition Assay | IC50=81.06 nM | SANGER | |||
| MKN45 | Growth Inhibition Assay | IC50=81.51 nM | SANGER | |||
| LoVo | Growth Inhibition Assay | IC50=81.82 nM | SANGER | |||
| SW1573 | Growth Inhibition Assay | IC50=82.81 nM | SANGER | |||
| ETK-1 | Growth Inhibition Assay | IC50=83.01 nM | SANGER | |||
| ABC-1 | Growth Inhibition Assay | IC50=83.45 nM | SANGER | |||
| COLO-668 | Growth Inhibition Assay | IC50=84.47 nM | SANGER | |||
| UM-UC-3 | Growth Inhibition Assay | IC50=86.02 nM | SANGER | |||
| BC-1 | Growth Inhibition Assay | IC50=86.76 nM | SANGER | |||
| PANC-10-05 | Growth Inhibition Assay | IC50=88.45 nM | SANGER | |||
| ES3 | Growth Inhibition Assay | IC50=89.48 nM | SANGER | |||
| TE-441-T | Growth Inhibition Assay | IC50=89.82 nM | SANGER | |||
| KM-H2 | Growth Inhibition Assay | IC50=90.68 nM | SANGER | |||
| SH-4 | Growth Inhibition Assay | IC50=92.11 nM | SANGER | |||
| SF268 | Growth Inhibition Assay | IC50=92.42 nM | SANGER | |||
| VMRC-RCZ | Growth Inhibition Assay | IC50=93.26 nM | SANGER | |||
| GI-ME-N | Growth Inhibition Assay | IC50=93.33 nM | SANGER | |||
| JEG-3 | Growth Inhibition Assay | IC50=95.12 nM | SANGER | |||
| J-RT3-T3-5 | Growth Inhibition Assay | IC50=96.31 nM | SANGER | |||
| K5 | Growth Inhibition Assay | IC50=96.9 nM | SANGER | |||
| EFO-27 | Growth Inhibition Assay | IC50=97.44 nM | SANGER | |||
| SW1783 | Growth Inhibition Assay | IC50=97.99 nM | SANGER | |||
| CAL-39 | Growth Inhibition Assay | IC50=98.24 nM | SANGER | |||
| LS-441N | Growth Inhibition Assay | IC50=99.06 nM | SANGER | |||
| G-402 | Growth Inhibition Assay | IC50=99.09 nM | SANGER | |||
| MES-SA | Growth Inhibition Assay | IC50=99.53 nM | SANGER | |||
| FADU | Growth Inhibition Assay | IC50=102.18 nM | SANGER | |||
| DJM-1 | Growth Inhibition Assay | IC50=102.25 nM | SANGER | |||
| SU-DHL-1 | Growth Inhibition Assay | IC50=102.5 nM | SANGER | |||
| KYSE-410 | Growth Inhibition Assay | IC50=103.46 nM | SANGER | |||
| NCI-H1618 | Growth Inhibition Assay | IC50=104.35 nM | SANGER | |||
| AU565 | Growth Inhibition Assay | IC50=104.51 nM | SANGER | |||
| SF126 | Growth Inhibition Assay | IC50=104.58 nM | SANGER | |||
| MMAC-SF | Growth Inhibition Assay | IC50=106.48 nM | SANGER | |||
| ChaGo-K-1 | Growth Inhibition Assay | IC50=107.95 nM | SANGER | |||
| NCI-H596 | Growth Inhibition Assay | IC50=108.01 nM | SANGER | |||
| LXF-289 | Growth Inhibition Assay | IC50=109.24 nM | SANGER | |||
| HCC1569 | Growth Inhibition Assay | IC50=109.34 nM | SANGER | |||
| NCI-H2170 | Growth Inhibition Assay | IC50=109.92 nM | SANGER | |||
| ARH-77 | Growth Inhibition Assay | IC50=109.99 nM | SANGER | |||
| BOKU | Growth Inhibition Assay | IC50=110.87 nM | SANGER | |||
| SJSA-1 | Growth Inhibition Assay | IC50=111.05 nM | SANGER | |||
| SW626 | Growth Inhibition Assay | IC50=111.71 nM | SANGER | |||
| EHEB | Growth Inhibition Assay | IC50=112.59 nM | SANGER | |||
| TE-10 | Growth Inhibition Assay | IC50=112.68 nM | SANGER | |||
| MZ7-mel | Growth Inhibition Assay | IC50=112.84 nM | SANGER | |||
| SAS | Growth Inhibition Assay | IC50=114.45 nM | SANGER | |||
| TK10 | Growth Inhibition Assay | IC50=114.6 nM | SANGER | |||
| SW13 | Growth Inhibition Assay | IC50=115.26 nM | SANGER | |||
| HCC1937 | Growth Inhibition Assay | IC50=115.84 nM | SANGER | |||
| SK-NEP-1 | Growth Inhibition Assay | IC50=116.26 nM | SANGER | |||
| OVCAR-5 | Growth Inhibition Assay | IC50=116.81 nM | SANGER | |||
| SW837 | Growth Inhibition Assay | IC50=117.95 nM | SANGER | |||
| BFTC-909 | Growth Inhibition Assay | IC50=118.48 nM | SANGER | |||
| SW872 | Growth Inhibition Assay | IC50=120.81 nM | SANGER | |||
| SF539 | Growth Inhibition Assay | IC50=121.72 nM | SANGER | |||
| MLMA | Growth Inhibition Assay | IC50=122.08 nM | SANGER | |||
| BL-41 | Growth Inhibition Assay | IC50=122.22 nM | SANGER | |||
| LB647-SCLC | Growth Inhibition Assay | IC50=123.35 nM | SANGER | |||
| NCI-H1703 | Growth Inhibition Assay | IC50=126.42 nM | SANGER | |||
| KURAMOCHI | Growth Inhibition Assay | IC50=126.76 nM | SANGER | |||
| ATN-1 | Growth Inhibition Assay | IC50=127.7 nM | SANGER | |||
| SK-CO-1 | Growth Inhibition Assay | IC50=129.21 nM | SANGER | |||
| RPMI-7951 | Growth Inhibition Assay | IC50=130.14 nM | SANGER | |||
| NCI-H1648 | Growth Inhibition Assay | IC50=131.94 nM | SANGER | |||
| NCI-H64 | Growth Inhibition Assay | IC50=132.65 nM | SANGER | |||
| HT-3 | Growth Inhibition Assay | IC50=133.04 nM | SANGER | |||
| NCI-H1770 | Growth Inhibition Assay | IC50=133.21 nM | SANGER | |||
| NB13 | Growth Inhibition Assay | IC50=134.55 nM | SANGER | |||
| NCI-H747 | Growth Inhibition Assay | IC50=135.02 nM | SANGER | |||
| ML-2 | Growth Inhibition Assay | IC50=135.16 nM | SANGER | |||
| CA46 | Growth Inhibition Assay | IC50=136.88 nM | SANGER | |||
| ES6 | Growth Inhibition Assay | IC50=137.12 nM | SANGER | |||
| JiyoyeP-2003 | Growth Inhibition Assay | IC50=137.8 nM | SANGER | |||
| NMC-G1 | Growth Inhibition Assay | IC50=139.13 nM | SANGER | |||
| U-698-M | Growth Inhibition Assay | IC50=139.5 nM | SANGER | |||
| LU-99A | Growth Inhibition Assay | IC50=146.55 nM | SANGER | |||
| NCI-H748 | Growth Inhibition Assay | IC50=147.31 nM | SANGER | |||
| SK-MEL-3 | Growth Inhibition Assay | IC50=147.61 nM | SANGER | |||
| SNB75 | Growth Inhibition Assay | IC50=148.65 nM | SANGER | |||
| BB65-RCC | Growth Inhibition Assay | IC50=149.31 nM | SANGER | |||
| NCI-H1355 | Growth Inhibition Assay | IC50=152.24 nM | SANGER | |||
| SCC-25 | Growth Inhibition Assay | IC50=153.73 nM | SANGER | |||
| OAW-42 | Growth Inhibition Assay | IC50=153.84 nM | SANGER | |||
| MONO-MAC-6 | Growth Inhibition Assay | IC50=154.36 nM | SANGER | |||
| WSU-NHL | Growth Inhibition Assay | IC50=154.58 nM | SANGER | |||
| SNU-423 | Growth Inhibition Assay | IC50=155.34 nM | SANGER | |||
| SBC-1 | Growth Inhibition Assay | IC50=156.4 nM | SANGER | |||
| OVCAR-4 | Growth Inhibition Assay | IC50=156.78 nM | SANGER | |||
| NCI-H2347 | Growth Inhibition Assay | IC50=158.34 nM | SANGER | |||
| CAMA-1 | Growth Inhibition Assay | IC50=159.33 nM | SANGER | |||
| GDM-1 | Growth Inhibition Assay | IC50=159.7 nM | SANGER | |||
| KNS-81-FD | Growth Inhibition Assay | IC50=160.32 nM | SANGER | |||
| no-10 | Growth Inhibition Assay | IC50=160.38 nM | SANGER | |||
| NCI-H2052 | Growth Inhibition Assay | IC50=160.47 nM | SANGER | |||
| DB | Growth Inhibition Assay | IC50=161.71 nM | SANGER | |||
| A4-Fuk | Growth Inhibition Assay | IC50=162.48 nM | SANGER | |||
| HCE-T | Growth Inhibition Assay | IC50=164.87 nM | SANGER | |||
| HuP-T3 | Growth Inhibition Assay | IC50=165.55 nM | SANGER | |||
| BC-3 | Growth Inhibition Assay | IC50=165.86 nM | SANGER | |||
| RVH-421 | Growth Inhibition Assay | IC50=169.13 nM | SANGER | |||
| COLO-800 | Growth Inhibition Assay | IC50=171.8 nM | SANGER | |||
| OMC-1 | Growth Inhibition Assay | IC50=172.17 nM | SANGER | |||
| SJRH30 | Growth Inhibition Assay | IC50=172.94 nM | SANGER | |||
| HEL | Growth Inhibition Assay | IC50=175.15 nM | SANGER | |||
| KLE | Growth Inhibition Assay | IC50=175.47 nM | SANGER | |||
| MEG-01 | Growth Inhibition Assay | IC50=176.6 nM | SANGER | |||
| OAW-28 | Growth Inhibition Assay | IC50=178.84 nM | SANGER | |||
| RD | Growth Inhibition Assay | IC50=180.1 nM | SANGER | |||
| HCC2218 | Growth Inhibition Assay | IC50=181.66 nM | SANGER | |||
| OS-RC-2 | Growth Inhibition Assay | IC50=182.49 nM | SANGER | |||
| HEC-1 | Growth Inhibition Assay | IC50=182.83 nM | SANGER | |||
| SCC-4 | Growth Inhibition Assay | IC50=183.71 nM | SANGER | |||
| ME-180 | Growth Inhibition Assay | IC50=186.08 nM | SANGER | |||
| NB10 | Growth Inhibition Assay | IC50=188.09 nM | SANGER | |||
| SCC-15 | Growth Inhibition Assay | IC50=188.24 nM | SANGER | |||
| COR-L105 | Growth Inhibition Assay | IC50=188.92 nM | SANGER | |||
| HT-1376 | Growth Inhibition Assay | IC50=189.01 nM | SANGER | |||
| RPMI-8866 | Growth Inhibition Assay | IC50=192.13 nM | SANGER | |||
| NCI-H2126 | Growth Inhibition Assay | IC50=192.2 nM | SANGER | |||
| KARPAS-422 | Growth Inhibition Assay | IC50=193.41 nM | SANGER | |||
| COLO-741 | Growth Inhibition Assay | IC50=194.58 nM | SANGER | |||
| IPC-298 | Growth Inhibition Assay | IC50=196.21 nM | SANGER | |||
| OE19 | Growth Inhibition Assay | IC50=200.18 nM | SANGER | |||
| NCI-H1694 | Growth Inhibition Assay | IC50=200.26 nM | SANGER | |||
| SW1990 | Growth Inhibition Assay | IC50=201.9 nM | SANGER | |||
| LNCaP-Clone-FGC | Growth Inhibition Assay | IC50=204.47 nM | SANGER | |||
| LB831-BLC | Growth Inhibition Assay | IC50=206.25 nM | SANGER | |||
| HCT-116 | Growth Inhibition Assay | IC50=207.39 nM | SANGER | |||
| BxPC-3 | Growth Inhibition Assay | IC50=210.96 nM | SANGER | |||
| HT-1197 | Growth Inhibition Assay | IC50=212.58 nM | SANGER | |||
| GB-1 | Growth Inhibition Assay | IC50=212.73 nM | SANGER | |||
| RPMI-8226 | Growth Inhibition Assay | IC50=213.37 nM | SANGER | |||
| L-540 | Growth Inhibition Assay | IC50=213.49 nM | SANGER | |||
| NCI-H1882 | Growth Inhibition Assay | IC50=215 nM | SANGER | |||
| A673 | Growth Inhibition Assay | IC50=215.79 nM | SANGER | |||
| NCI-H650 | Growth Inhibition Assay | IC50=217.61 nM | SANGER | |||
| KM12 | Growth Inhibition Assay | IC50=218.15 nM | SANGER | |||
| KP-N-YS | Growth Inhibition Assay | IC50=218.4 nM | SANGER | |||
| COLO-684 | Growth Inhibition Assay | IC50=219.79 nM | SANGER | |||
| MHH-NB-11 | Growth Inhibition Assay | IC50=220.22 nM | SANGER | |||
| HO-1-N-1 | Growth Inhibition Assay | IC50=222.83 nM | SANGER | |||
| NOMO-1 | Growth Inhibition Assay | IC50=224.43 nM | SANGER | |||
| KYSE-70 | Growth Inhibition Assay | IC50=224.66 nM | SANGER | |||
| NCI-H838 | Growth Inhibition Assay | IC50=224.73 nM | SANGER | |||
| NY | Growth Inhibition Assay | IC50=228.49 nM | SANGER | |||
| NCI-H2196 | Growth Inhibition Assay | IC50=229.15 nM | SANGER | |||
| FTC-133 | Growth Inhibition Assay | IC50=229.37 nM | SANGER | |||
| MHH-PREB-1 | Growth Inhibition Assay | IC50=229.82 nM | SANGER | |||
| SK-MEL-2 | Growth Inhibition Assay | IC50=230.3 nM | SANGER | |||
| Detroit562 | Growth Inhibition Assay | IC50=230.72 nM | SANGER | |||
| NCI-H2405 | Growth Inhibition Assay | IC50=234.1 nM | SANGER | |||
| NCI-H2081 | Growth Inhibition Assay | IC50=234.27 nM | SANGER | |||
| LB2241-RCC | Growth Inhibition Assay | IC50=235.11 nM | SANGER | |||
| SNU-387 | Growth Inhibition Assay | IC50=236.08 nM | SANGER | |||
| PC-14 | Growth Inhibition Assay | IC50=236.12 nM | SANGER | |||
| CAS-1 | Growth Inhibition Assay | IC50=238.31 nM | SANGER | |||
| TE-11 | Growth Inhibition Assay | IC50=240.88 nM | SANGER | |||
| LC4-1 | Growth Inhibition Assay | IC50=240.89 nM | SANGER | |||
| HH | Growth Inhibition Assay | IC50=241.46 nM | SANGER | |||
| JVM-2 | Growth Inhibition Assay | IC50=242.17 nM | SANGER | |||
| KNS-42 | Growth Inhibition Assay | IC50=242.67 nM | SANGER | |||
| T-24 | Growth Inhibition Assay | IC50=245.48 nM | SANGER | |||
| D-392MG | Growth Inhibition Assay | IC50=248.5 nM | SANGER | |||
| KOSC-2 | Growth Inhibition Assay | IC50=248.71 nM | SANGER | |||
| D-283MED | Growth Inhibition Assay | IC50=250.13 nM | SANGER | |||
| BV-173 | Growth Inhibition Assay | IC50=250.77 nM | SANGER | |||
| EW-18 | Growth Inhibition Assay | IC50=250.9 nM | SANGER | |||
| MS-1 | Growth Inhibition Assay | IC50=252.53 nM | SANGER | |||
| Calu-6 | Growth Inhibition Assay | IC50=253.55 nM | SANGER | |||
| GR-ST | Growth Inhibition Assay | IC50=255.42 nM | SANGER | |||
| GAK | Growth Inhibition Assay | IC50=256.91 nM | SANGER | |||
| TE-9 | Growth Inhibition Assay | IC50=257.47 nM | SANGER | |||
| HuH-7 | Growth Inhibition Assay | IC50=258.44 nM | SANGER | |||
| KYSE-520 | Growth Inhibition Assay | IC50=260.77 nM | SANGER | |||
| NCI-H520 | Growth Inhibition Assay | IC50=266.61 nM | SANGER | |||
| HD-MY-Z | Growth Inhibition Assay | IC50=272.79 nM | SANGER | |||
| SW756 | Growth Inhibition Assay | IC50=274.78 nM | SANGER | |||
| NB12 | Growth Inhibition Assay | IC50=277.12 nM | SANGER | |||
| EW-3 | Growth Inhibition Assay | IC50=279.89 nM | SANGER | |||
| AM-38 | Growth Inhibition Assay | IC50=281.52 nM | SANGER | |||
| NCI-H23 | Growth Inhibition Assay | IC50=283.92 nM | SANGER | |||
| GOTO | Growth Inhibition Assay | IC50=285.56 nM | SANGER | |||
| NCI-H1693 | Growth Inhibition Assay | IC50=290.32 nM | SANGER | |||
| MOLT-16 | Growth Inhibition Assay | IC50=290.5 nM | SANGER | |||
| HOP-92 | Growth Inhibition Assay | IC50=290.7 nM | SANGER | |||
| MDA-MB-361 | Growth Inhibition Assay | IC50=292.65 nM | SANGER | |||
| Ramos-2G6-4C10 | Growth Inhibition Assay | IC50=294.55 nM | SANGER | |||
| CAL-54 | Growth Inhibition Assay | IC50=300.73 nM | SANGER | |||
| D-263MG | Growth Inhibition Assay | IC50=305.52 nM | SANGER | |||
| SKG-IIIa | Growth Inhibition Assay | IC50=311.14 nM | SANGER | |||
| HAL-01 | Growth Inhibition Assay | IC50=313.44 nM | SANGER | |||
| LAN-6 | Growth Inhibition Assay | IC50=315.11 nM | SANGER | |||
| NCI-H1304 | Growth Inhibition Assay | IC50=321.17 nM | SANGER | |||
| no-11 | Growth Inhibition Assay | IC50=321.64 nM | SANGER | |||
| IST-MES1 | Growth Inhibition Assay | IC50=323.35 nM | SANGER | |||
| L-363 | Growth Inhibition Assay | IC50=324.43 nM | SANGER | |||
| EM-2 | Growth Inhibition Assay | IC50=325.41 nM | SANGER | |||
| DV-90 | Growth Inhibition Assay | IC50=329.45 nM | SANGER | |||
| Saos-2 | Growth Inhibition Assay | IC50=329.94 nM | SANGER | |||
| UMC-11 | Growth Inhibition Assay | IC50=331.28 nM | SANGER | |||
| Raji | Growth Inhibition Assay | IC50=334.64 nM | SANGER | |||
| RXF393 | Growth Inhibition Assay | IC50=335.43 nM | SANGER | |||
| EW-11 | Growth Inhibition Assay | IC50=341.56 nM | SANGER | |||
| BL-70 | Growth Inhibition Assay | IC50=342.01 nM | SANGER | |||
| LB373-MEL-D | Growth Inhibition Assay | IC50=344.64 nM | SANGER | |||
| LU-139 | Growth Inhibition Assay | IC50=344.92 nM | SANGER | |||
| U-87-MG | Growth Inhibition Assay | IC50=346.04 nM | SANGER | |||
| LU-65 | Growth Inhibition Assay | IC50=346.4 nM | SANGER | |||
| U031 | Growth Inhibition Assay | IC50=353.87 nM | SANGER | |||
| HN | Growth Inhibition Assay | IC50=354.27 nM | SANGER | |||
| MHH-CAL-2 | Growth Inhibition Assay | IC50=359.21 nM | SANGER | |||
| NCI-H510A | Growth Inhibition Assay | IC50=359.59 nM | SANGER | |||
| NB5 | Growth Inhibition Assay | IC50=359.81 nM | SANGER | |||
| KG-1 | Growth Inhibition Assay | IC50=361.52 nM | SANGER | |||
| EFO-21 | Growth Inhibition Assay | IC50=361.85 nM | SANGER | |||
| UACC-257 | Growth Inhibition Assay | IC50=362.05 nM | SANGER | |||
| SW1417 | Growth Inhibition Assay | IC50=363.23 nM | SANGER | |||
| NCI-H1417 | Growth Inhibition Assay | IC50=370.04 nM | SANGER | |||
| DSH1 | Growth Inhibition Assay | IC50=372.72 nM | SANGER | |||
| CAKI-1 | Growth Inhibition Assay | IC50=375.48 nM | SANGER | |||
| SIMA | Growth Inhibition Assay | IC50=381.86 nM | SANGER | |||
| LS-1034 | Growth Inhibition Assay | IC50=384.51 nM | SANGER | |||
| K-562 | Growth Inhibition Assay | IC50=385.8 nM | SANGER | |||
| LOXIMVI | Growth Inhibition Assay | IC50=389.19 nM | SANGER | |||
| MC116 | Growth Inhibition Assay | IC50=391.41 nM | SANGER | |||
| MPP-89 | Growth Inhibition Assay | IC50=392.94 nM | SANGER | |||
| SN12C | Growth Inhibition Assay | IC50=394.87 nM | SANGER | |||
| BHT-101 | Growth Inhibition Assay | IC50=395.92 nM | SANGER | |||
| DMS-114 | Growth Inhibition Assay | IC50=396.31 nM | SANGER | |||
| NCI-H1838 | Growth Inhibition Assay | IC50=405.05 nM | SANGER | |||
| HT | Growth Inhibition Assay | IC50=405.15 nM | SANGER | |||
| Caov-3 | Growth Inhibition Assay | IC50=406.19 nM | SANGER | |||
| LB2518-MEL | Growth Inhibition Assay | IC50=413.1 nM | SANGER | |||
| C3A | Growth Inhibition Assay | IC50=415.79 nM | SANGER | |||
| NCI-H226 | Growth Inhibition Assay | IC50=416.64 nM | SANGER | |||
| KMS-12-PE | Growth Inhibition Assay | IC50=418.06 nM | SANGER | |||
| RERF-LC-MS | Growth Inhibition Assay | IC50=425.05 nM | SANGER | |||
| OE33 | Growth Inhibition Assay | IC50=426.02 nM | SANGER | |||
| COLO-678 | Growth Inhibition Assay | IC50=427.18 nM | SANGER | |||
| NCI-H1963 | Growth Inhibition Assay | IC50=430.11 nM | SANGER | |||
| LAMA-84 | Growth Inhibition Assay | IC50=437.3 nM | SANGER | |||
| NCI-H2171 | Growth Inhibition Assay | IC50=440.67 nM | SANGER | |||
| U-266 | Growth Inhibition Assay | IC50=451.49 nM | SANGER | |||
| SNU-C2B | Growth Inhibition Assay | IC50=460.97 nM | SANGER | |||
| T47D | Growth Inhibition Assay | IC50=469.69 nM | SANGER | |||
| TE-6 | Growth Inhibition Assay | IC50=469.81 nM | SANGER | |||
| OVCAR-3 | Growth Inhibition Assay | IC50=470.41 nM | SANGER | |||
| C-4-II | Growth Inhibition Assay | IC50=472.56 nM | SANGER | |||
| EFM-19 | Growth Inhibition Assay | IC50=478.27 nM | SANGER | |||
| NCI-N87 | Growth Inhibition Assay | IC50=479.92 nM | SANGER | |||
| NCI-H187 | Growth Inhibition Assay | IC50=493.21 nM | SANGER | |||
| MDA-MB-157 | Growth Inhibition Assay | IC50=499.01 nM | SANGER | |||
| OPM-2 | Growth Inhibition Assay | IC50=501.81 nM | SANGER | |||
| COLO-320-HSR | Growth Inhibition Assay | IC50=513.16 nM | SANGER | |||
| RMG-I | Growth Inhibition Assay | IC50=513.98 nM | SANGER | |||
| IST-SL1 | Growth Inhibition Assay | IC50=517.42 nM | SANGER | |||
| UACC-893 | Growth Inhibition Assay | IC50=521.51 nM | SANGER | |||
| Becker | Growth Inhibition Assay | IC50=521.83 nM | SANGER | |||
| HPAF-II | Growth Inhibition Assay | IC50=527.24 nM | SANGER | |||
| HCC1954 | Growth Inhibition Assay | IC50=540.83 nM | SANGER | |||
| SNU-449 | Growth Inhibition Assay | IC50=548.01 nM | SANGER | |||
| NCI-H1563 | Growth Inhibition Assay | IC50=556.49 nM | SANGER | |||
| HDLM-2 | Growth Inhibition Assay | IC50=568.59 nM | SANGER | |||
| NCI-H69 | Growth Inhibition Assay | IC50=568.8 nM | SANGER | |||
| NCI-SNU-5 | Growth Inhibition Assay | IC50=570.15 nM | SANGER | |||
| NCI-H1792 | Growth Inhibition Assay | IC50=572.43 nM | SANGER | |||
| NCI-H2141 | Growth Inhibition Assay | IC50=573.69 nM | SANGER | |||
| KMOE-2 | Growth Inhibition Assay | IC50=576.32 nM | SANGER | |||
| NCI-H1155 | Growth Inhibition Assay | IC50=579.87 nM | SANGER | |||
| LK-2 | Growth Inhibition Assay | IC50=581.07 nM | SANGER | |||
| HCC1187 | Growth Inhibition Assay | IC50=591.47 nM | SANGER | |||
| EGI-1 | Growth Inhibition Assay | IC50=598.27 nM | SANGER | |||
| NCI-H1623 | Growth Inhibition Assay | IC50=604.6 nM | SANGER | |||
| MN-60 | Growth Inhibition Assay | IC50=605.37 nM | SANGER | |||
| JAR | Growth Inhibition Assay | IC50=625.95 nM | SANGER | |||
| HCC1419 | Growth Inhibition Assay | IC50=631.74 nM | SANGER | |||
| LU-165 | Growth Inhibition Assay | IC50=639.4 nM | SANGER | |||
| TYK-nu | Growth Inhibition Assay | IC50=662.55 nM | SANGER | |||
| DG-75 | Growth Inhibition Assay | IC50=665.83 nM | SANGER | |||
| PFSK-1 | Growth Inhibition Assay | IC50=678.08 nM | SANGER | |||
| MKN7 | Growth Inhibition Assay | IC50=689.95 nM | SANGER | |||
| DMS-153 | Growth Inhibition Assay | IC50=698.15 nM | SANGER | |||
| HTC-C3 | Growth Inhibition Assay | IC50=703.94 nM | SANGER | |||
| GCIY | Growth Inhibition Assay | IC50=725.12 nM | SANGER | |||
| NCI-H1092 | Growth Inhibition Assay | IC50=737.95 nM | SANGER | |||
| EB-3 | Growth Inhibition Assay | IC50=771.02 nM | SANGER | |||
| CAL-120 | Growth Inhibition Assay | IC50=777.52 nM | SANGER | |||
| BT-474 | Growth Inhibition Assay | IC50=778.81 nM | SANGER | |||
| L-428 | Growth Inhibition Assay | IC50=790.9 nM | SANGER | |||
| Mo-T | Growth Inhibition Assay | IC50=804.65 nM | SANGER | |||
| CAL-72 | Growth Inhibition Assay | IC50=840.67 nM | SANGER | |||
| AsPC-1 | Growth Inhibition Assay | IC50=855.26 nM | SANGER | |||
| U-118-MG | Growth Inhibition Assay | IC50=856.34 nM | SANGER | |||
| GCT | Growth Inhibition Assay | IC50=861.48 nM | SANGER | |||
| EKVX | Growth Inhibition Assay | IC50=871.87 nM | SANGER | |||
| NCI-H1755 | Growth Inhibition Assay | IC50=873.52 nM | SANGER | |||
| Capan-2 | Growth Inhibition Assay | IC50=898.11 nM | SANGER | |||
| NCI-H1793 | Growth Inhibition Assay | IC50=900.87 nM | SANGER | |||
| PLC-PRF-5 | Growth Inhibition Assay | IC50=901.35 nM | SANGER | |||
| M14 | Growth Inhibition Assay | IC50=905.27 nM | SANGER | |||
| SK-MEL-24 | Growth Inhibition Assay | IC50=914.35 nM | SANGER | |||
| SK-MM-2 | Growth Inhibition Assay | IC50=942.3 nM | SANGER | |||
| PC-3 | Growth Inhibition Assay | IC50=957.22 nM | SANGER | |||
| EW-24 | Growth Inhibition Assay | IC50=970.4 nM | SANGER | |||
| MDA-MB-175-VII | Growth Inhibition Assay | IC50=971.53 nM | SANGER | |||
| NCI-H1581 | Growth Inhibition Assay | IC50=981.31 nM | SANGER | |||
| THP-1 | Growth Inhibition Assay | IC50=989.42 nM | SANGER | |||
| NCI-H1993 | Growth Inhibition Assay | IC50=1.00076 μM | SANGER | |||
| DOK | Growth Inhibition Assay | IC50=1.01762 μM | SANGER | |||
| KINGS-1 | Growth Inhibition Assay | IC50=1.019 μM | SANGER | |||
| YT | Growth Inhibition Assay | IC50=1.04568 μM | SANGER | |||
| TGBC1TKB | Growth Inhibition Assay | IC50=1.06036 μM | SANGER | |||
| TCCSUP | Growth Inhibition Assay | IC50=1.23083 μM | SANGER | |||
| BEN | Growth Inhibition Assay | IC50=1.23742 μM | SANGER | |||
| KARPAS-45 | Growth Inhibition Assay | IC50=1.26763 μM | SANGER | |||
| COLO-829 | Growth Inhibition Assay | IC50=1.2748 μM | SANGER | |||
| UACC-62 | Growth Inhibition Assay | IC50=1.32145 μM | SANGER | |||
| NCI-H446 | Growth Inhibition Assay | IC50=1.33771 μM | SANGER | |||
| RO82-W-1 | Growth Inhibition Assay | IC50=1.34337 μM | SANGER | |||
| NCI-H2452 | Growth Inhibition Assay | IC50=1.37129 μM | SANGER | |||
| RL | Growth Inhibition Assay | IC50=1.42066 μM | SANGER | |||
| NCI-H1522 | Growth Inhibition Assay | IC50=1.43159 μM | SANGER | |||
| TGW | Growth Inhibition Assay | IC50=1.45942 μM | SANGER | |||
| HT55 | Growth Inhibition Assay | IC50=1.47168 μM | SANGER | |||
| KARPAS-299 | Growth Inhibition Assay | IC50=1.47841 μM | SANGER | |||
| KY821 | Growth Inhibition Assay | IC50=1.49429 μM | SANGER | |||
| MDA-MB-231 | Growth Inhibition Assay | IC50=1.53055 μM | SANGER | |||
| NCI-H82 | Growth Inhibition Assay | IC50=1.57026 μM | SANGER | |||
| MDA-MB-134-VI | Growth Inhibition Assay | IC50=1.61711 μM | SANGER | |||
| PANC-08-13 | Growth Inhibition Assay | IC50=1.63084 μM | SANGER | |||
| D-542MG | Growth Inhibition Assay | IC50=1.65305 μM | SANGER | |||
| LC-1F | Growth Inhibition Assay | IC50=1.66203 μM | SANGER | |||
| KP-N-YN | Growth Inhibition Assay | IC50=1.66343 μM | SANGER | |||
| MFE-280 | Growth Inhibition Assay | IC50=1.66812 μM | SANGER | |||
| S-117 | Growth Inhibition Assay | IC50=1.70504 μM | SANGER | |||
| NCI-H1573 | Growth Inhibition Assay | IC50=1.71733 μM | SANGER | |||
| BT-20 | Growth Inhibition Assay | IC50=1.74068 μM | SANGER | |||
| NCI-H28 | Growth Inhibition Assay | IC50=1.74078 μM | SANGER | |||
| CaR-1 | Growth Inhibition Assay | IC50=1.78324 μM | SANGER | |||
| LN-405 | Growth Inhibition Assay | IC50=1.80143 μM | SANGER | |||
| RT4 | Growth Inhibition Assay | IC50=1.84417 μM | SANGER | |||
| NCI-H889 | Growth Inhibition Assay | IC50=1.93886 μM | SANGER | |||
| SW1463 | Growth Inhibition Assay | IC50=1.95701 μM | SANGER | |||
| SCLC-21H | Growth Inhibition Assay | IC50=2.00624 μM | SANGER | |||
| CP66-MEL | Growth Inhibition Assay | IC50=2.01767 μM | SANGER | |||
| Hs-578-T | Growth Inhibition Assay | IC50=2.01782 μM | SANGER | |||
| HCC70 | Growth Inhibition Assay | IC50=2.05463 μM | SANGER | |||
| SW1088 | Growth Inhibition Assay | IC50=2.06931 μM | SANGER | |||
| NB6 | Growth Inhibition Assay | IC50=2.185 μM | SANGER | |||
| KU-19-19 | Growth Inhibition Assay | IC50=2.26917 μM | SANGER | |||
| A704 | Growth Inhibition Assay | IC50=2.29135 μM | SANGER | |||
| EVSA-T | Growth Inhibition Assay | IC50=2.30089 μM | SANGER | |||
| HCT-15 | Growth Inhibition Assay | IC50=2.35466 μM | SANGER | |||
| HuO-3N1 | Growth Inhibition Assay | IC50=2.36583 μM | SANGER | |||
| GMS-10 | Growth Inhibition Assay | IC50=2.39738 μM | SANGER | |||
| TGBC24TKB | Growth Inhibition Assay | IC50=2.41429 μM | SANGER | |||
| C2BBe1 | Growth Inhibition Assay | IC50=2.51328 μM | SANGER | |||
| SK-N-DZ | Growth Inhibition Assay | IC50=2.56592 μM | SANGER | |||
| SK-N-AS | Growth Inhibition Assay | IC50=2.73015 μM | SANGER | |||
| T98G | Growth Inhibition Assay | IC50=2.80401 μM | SANGER | |||
| DMS-79 | Growth Inhibition Assay | IC50=2.90988 μM | SANGER | |||
| SNU-475 | Growth Inhibition Assay | IC50=2.92572 μM | SANGER | |||
| COLO-792 | Growth Inhibition Assay | IC50=3.0287 μM | SANGER | |||
| YAPC | Growth Inhibition Assay | IC50=3.32832 μM | SANGER | |||
| UACC-812 | Growth Inhibition Assay | IC50=3.33738 μM | SANGER | |||
| Mewo | Growth Inhibition Assay | IC50=3.46086 μM | SANGER | |||
| COLO-824 | Growth Inhibition Assay | IC50=3.57378 μM | SANGER | |||
| SCC-9 | Growth Inhibition Assay | IC50=3.91309 μM | SANGER | |||
| CP50-MEL-B | Growth Inhibition Assay | IC50=3.98703 μM | SANGER | |||
| NCI-H345 | Growth Inhibition Assay | IC50=4.01174 μM | SANGER | |||
| COR-L88 | Growth Inhibition Assay | IC50=4.3958 μM | SANGER | |||
| RCM-1 | Growth Inhibition Assay | IC50=4.49272 μM | SANGER | |||
| JVM-3 | Growth Inhibition Assay | IC50=4.60618 μM | SANGER | |||
| ECC4 | Growth Inhibition Assay | IC50=4.76541 μM | SANGER | |||
| MDA-MB-453 | Growth Inhibition Assay | IC50=4.85134 μM | SANGER | |||
| SK-N-FI | Growth Inhibition Assay | IC50=5.22877 μM | SANGER | |||
| D-502MG | Growth Inhibition Assay | IC50=5.24262 μM | SANGER | |||
| NCI-H2227 | Growth Inhibition Assay | IC50=5.36231 μM | SANGER | |||
| DMS-53 | Growth Inhibition Assay | IC50=6.17106 μM | SANGER | |||
| LB771-HNC | Growth Inhibition Assay | IC50=6.46806 μM | SANGER | |||
| BB49-HNC | Growth Inhibition Assay | IC50=7.41791 μM | SANGER | |||
| MDA-MB-415 | Growth Inhibition Assay | IC50=7.57303 μM | SANGER | |||
| TALL-1 | Growth Inhibition Assay | IC50=7.9688 μM | SANGER | |||
| HCC1395 | Growth Inhibition Assay | IC50=8.15122 μM | SANGER | |||
| EFE-184 | Growth Inhibition Assay | IC50=8.37216 μM | SANGER | |||
| EC-GI-10 | Growth Inhibition Assay | IC50=8.68686 μM | SANGER | |||
| TT | Growth Inhibition Assay | IC50=9.06966 μM | SANGER | |||
| U-2-OS | Growth Inhibition Assay | IC50=9.81393 μM | SANGER | |||
| SHP-77 | Growth Inhibition Assay | IC50=9.9029 μM | SANGER | |||
| HCC1143 | Growth Inhibition Assay | IC50=10.4797 μM | SANGER | |||
| A498 | Growth Inhibition Assay | IC50=18.2976 μM | SANGER | |||
| LS-513 | Growth Inhibition Assay | IC50=18.6093 μM | SANGER | |||
| K052 | Growth Inhibition Assay | IC50=21.4418 μM | SANGER | |||
| SiHa | Growth Inhibition Assay | IC50=23.3371 μM | SANGER | |||
| RCC10RGB | Growth Inhibition Assay | IC50=30.0611 μM | SANGER | |||
| NCI-SNU-16 | Growth Inhibition Assay | IC50=31.1836 μM | SANGER | |||
| SNU-C1 | Growth Inhibition Assay | IC50=32.4175 μM | SANGER | |||
| C32 | Growth Inhibition Assay | IC50=32.872 μM | SANGER | |||
| SW684 | Growth Inhibition Assay | IC50=34.1561 μM | SANGER | |||
| SK-MEL-28 | Growth Inhibition Assay | IC50=35.5377 μM | SANGER | |||
| SK-MEL-1 | Growth Inhibition Assay | IC50=36.7547 μM | SANGER | |||
| NCI-H720 | Growth Inhibition Assay | IC50=41.9726 μM | SANGER | |||
| P31-FUJ | Growth Inhibition Assay | IC50=44.3284 μM | SANGER | |||
| NCI-H524 | Growth Inhibition Assay | IC50=48.8248 μM | SANGER | |||
| Cliquez pour voir plus de données expérimentales sur les lignées cellulaires | ||||||
| Poids moléculaire | 579.98 | Formule | C27H29NO11.HCl |
Stockage (À partir de la date de réception) | |
|---|---|---|---|---|---|
| N° CAS | 25316-40-9 | Télécharger le SDF | Stockage des solutions mères |
|
|
| Synonymes | Adriamycin, NSC 123127, Hydroxydaunorubicin HCl | Smiles | CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl | ||
|
In vitro |
DMSO
: 100 mg/mL
(172.41 mM)
Water : 100 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
Étape 1 : Entrez les informations ci-dessous (Recommandé : Un animal supplémentaire pour tenir compte des pertes pendant lexpérience)
Étape 2 : Entrez la formulation in vivo (Ceci nest que le calculateur, pas la formulation. Veuillez nous contacter dabord sil ny a pas de formulation in vivo dans la section Solubilité.)
Résultats du calcul :
Concentration de travail : mg/ml;
Méthode de préparation du liquide maître DMSO : mg médicament prédissous dans μL DMSO ( Concentration du liquide maître mg/mL, Veuillez nous contacter dabord si la concentration dépasse la solubilité du DMSO du lot de médicament. )
Méthode de préparation de la formulation in vivo : Prendre μL DMSO liquide maître, ajouter ensuiteμL PEG300, mélanger et clarifier, ajouter ensuiteμL Tween 80, mélanger et clarifier, ajouter ensuite μL ddH2O, mélanger et clarifier.
Méthode de préparation de la formulation in vivo : Prendre μL DMSO liquide maître, ajouter ensuite μL Huile de maïs, mélanger et clarifier.
Remarque : 1. Assurez-vous que le liquide est clair avant dajouter le solvant suivant.
2. Assurez-vous dajouter le(s) solvant(s) dans lordre. Vous devez vous assurer que la solution obtenue lors de lajout précédent est une solution claire avant de procéder à lajout du solvant suivant. Des méthodes physiques telles que le vortex, les ultrasons ou le bain-marie peuvent être utilisées pour faciliter la dissolution.
| Targets/IC50/Ki |
AMPK
Topo II
(Tumor cells) |
|---|---|
| In vitro |
La Doxorubicin, une anthracycline antibiotique, est généralement considérée comme exerçant son activité antitumorale à deux niveaux fondamentaux : altérer l'ADN et produire des radicaux libres pour déclencher l'apoptose des cellules cancéreuses par des lésions de l'ADN. La Doxorubicin peut bloquer la synthèse de l'ADN en s'intercalant dans le brin d'ADN, et inhibe la DNA topoisomerase II (TOP2). La Doxorubicin est plus efficace lorsque les cellules prolifèrent rapidement et expriment des niveaux élevés de TOP2. De plus, la Doxorubicin peut déclencher l'apoptose en produisant de la céramide (qui provoque l'apoptose en activant p53 ou d'autres voies en aval comme JNK), la dégradation d'Akt par les sérine-thréonine protéases, la libération mitochondriale du cytochrome c, une production accrue d'ARNm de FasL (ligand du récepteur de mort Fas/CD95), et une plus grande production de radicaux libres. Le prétraitement avec le GSNO (nitrosoglutathion) supprime la résistance dans la lignée cellulaire de cancer du sein résistante à la doxorubicine MCF7/Dx, accompagné d'une glutathionylation des protéines améliorée et d'une accumulation de doxorubicine dans le noyau. L'arrêt du point de contrôle G2/M induit par la Doxorubicin est attribué à une expression élevée de la cycline G2 (CycG2) et à une phospho-modification des protéines dans les voies de signalisation de l'ataxie télangiectasie mutée (ATM) et ATM et Rad3-related (ATR). La Doxorubicin inhibe la protéine kinase activée par l'AMP (AMPK), entraînant un dysfonctionnement de SIRT1, une accumulation de p53 et une augmentation de la mort cellulaire dans les fibroblastes embryonnaires de souris (MEF) et les cardiomyocytes, qui peuvent être davantage sensibilisés par une pré-inhibition de l'AMPK. La Doxorubicin déclenche une réponse marquée au choc thermique, et l'inhibition ou le silençage des protéines de choc thermique améliorent l'effet apoptotique de la Doxorubicin dans les cellules de neuroblastome. Le traitement nanomolaire à la Doxorubicin des cellules de neuroblastome provoque une sur-ubiquitination dépendante de la dose d'un ensemble spécifique de protéines en l'absence d'inhibition mesurable du protéasome, et une perte d'activité des enzymes ubiquitinées telles que la lactate déshydrogénase et l'α-énolase, dont les profils d'ubiquitination des protéines sont similaires à ceux observés avec l'inhibiteur du protéasome, ce qui indique que la Doxorubicin pourrait également exercer son effet en endommageant les protéines. |
| In vivo |
In vivo, la Doxorubicin en combinaison avec l'AdMnSOD adénoviral (AdMnSOD) plus le 1,3-bis(2-chloroéthyl)-1-nitrosourée (BCNU) a le plus grand effet sur la diminution des volumes des tumeurs MB231 et la prolongation de la survie des souris. Bien que son utilisation soit limitée par les effets secondaires toxiques chroniques et aigus qu'elle produit, la Doxorubicin est essentielle dans le traitement des carcinomes du sein et de l'œsophage, des tumeurs solides de l'enfant, des ostéosarcomes, du sarcome de Kaposi, des sarcomes des tissus mous et des lymphomes de Hodgkin et non hodgkiniens. |
Références |
|
| Méthodes | Biomarqueurs | Images | PMID |
|---|---|---|---|
| Western blot | POU5F1 / SOX2 / NANOG ATG5 / ATG7 / SQSTM1 / LC3A-II / LC3B-II / p-mTOR P62 / LC3II p-AKT(T308) / p-Akt(S473) / Akt / p-PRAS40(T246) / PRAS40 / p-H2A.X(S139) |
|
27929731 |
| Growth inhibition assay | Cell viability |
|
25871400 |
| Immunofluorescence | LC3 |
|
24970805 |
| ELISA | OPN |
|
24963635 |
(données de https://clinicaltrials.gov, mis à jour le 2024-05-22)
| Numéro NCT | Recrutement | Conditions | Sponsor/Collaborateurs | Date de début | Phases |
|---|---|---|---|---|---|
| NCT06186700 | Active not recruiting | Breast Cancer Female |
Mansoura University |
December 25 2023 | Phase 2 |
| NCT05567601 | Not yet recruiting | Ovarian Cancer|AIDS-related Kaposi Sarcoma|Multiple Myeloma|Metastatic Breast Cancer |
Baxter Healthcare Corporation |
November 30 2023 | Phase 1 |
| NCT06088290 | Recruiting | Leiomyosarcoma |
PharmaMar |
September 21 2023 | Phase 2|Phase 3 |
| NCT05748834 | Recruiting | Breast Cancer |
SCRI Development Innovations LLC|Seagen Inc. |
July 24 2023 | Phase 2 |
| NCT05853120 | Recruiting | Sexually Transmitted Diseases |
Emory University|Centers for Disease Control and Prevention |
May 31 2023 | Phase 4 |
Tel: +1-832-582-8158 Ext:3
Si vous avez dautres questions, veuillez laisser un message.
Question 1:
Why did the IC50 of it vary over time in our measurement?
Réponse :
Sometimes the IC50 value might vary between different batch of compounds due to the slight differences in purity. If different IC50 was seen in the same batch of it, the problem may lies in the process of dissolvement. Make sure that you see no particles and the solution is clear with your stock solution.